7 days in healthcare (January 26th-February 1st, 2026)

 

Summary

The week’s most impactful health news stories were:

  • Biomedicine: AlphaGenome, a Google AI, predicts the impact of DNA variations.
  • Global Health: The humanitarian situation in Yemen will worsen in 2026.
  • International Health Policy: Following donations, the Trump Administration rescinds the order requiring more staff in nursing homes.
  • National Health Policy: The Ministry of Health signs the Framework Statute agreement with unions, but without the support of doctors.
  • Business: According to Elon Musk, there will be no nursing homes in the future; he claims his robots will be able to protect and care for the elderly.

Biomedicine

  • AlphaGenome, a Google AI, predicts the impact of DNA variations. This tool could be used to obtain more information about genetic diseases, improve genetic testing, and contribute to the development of new treatments.
  • Genes control longevity, regardless of how healthy a lifestyle is. Each person’s life expectancy potential is written in their genes, according to a new study.
  • AI improves mammogram readings: it detects more tumors, especially the most aggressive ones, and reduces the number of missed ones. A Swedish clinical trial with more than 100,000 women shows that AI in mammogram screening detects more relevant cancers without increasing false positives.

Global Health

  • The humanitarian situation in Yemen will worsen in 2026. An 11-year-long civil war will contribute to the spread of infectious diseases, malnutrition, and maternal mortality.
  • How to eat well within Earth’s limits. The impact of new recommendations from RFK Jr., which call for increased protein, fruit, and vegetable consumption, is discussed.

International Health Policy

  • Following donations, the Trump Administration rescinds the order requiring more staff at nursing homes. According to the New York Times, executives from these companies met with Trump, made a significant donation, and the project was withdrawn.
  • China is changing the rules in biotech. For over 100 years, the USA was the undisputed leader in biomedical research and innovation. China’s major advances put the USA at risk of losing that position.
  • According to the British Prime Minister, the drop in vaccinations in the UK is a “national disgrace.” The vaccination strategy in England is failing.
  • How politics destroyed a model healthcare system in Colombia. For the last two decades, Colombia’s healthcare system was seen as an example for the rest of Latin America, both by the WHO and the World Bank. None of that changed President Petro’s mind, and he is trying to impose a radical change.

National Health Policy (Spain)

  • The Ministry of Health signs the agreement on the Framework Statute with the unions, but without the support of the doctors. Logically, in any healthcare system, doctors are not just another part. They are the key players most closely related to the quality of care. Their lack of agreement is not something that can be disregarded; rather, it invalidates any agreement. The doctors are prepared to continue defending their position through parliamentary channels.
  • A book by FUNCAS challenges the entrenched myths (or myths) about the Spanish public healthcare system. Whether we have the best healthcare system in the world, whether there is a shortage of doctors in Spain, or whether there is truly a shortage of 100,000 nurses, are among the topics analyzed. Among other things, it discusses whether we have the best or one of the best healthcare systems in the world. We do now have some health outcomes that can be correlated with the activity of the healthcare system. In fact, Spain ranked 9th among all countries in the world in the HAQ index (which measures clinically avoidable mortality) in 2022, with only eight countries ahead of it, all of them smaller (Switzerland, Sweden, Norway, Canada, the Netherlands, Australia, Iceland, and Ireland). Now, even if we were number one in health outcomes, that wouldn’t authorize us to say we have the best healthcare system in the world. It’s important to remember that the purpose of healthcare systems isn’t just to “save lives.” They have other valuable functions, difficult to reflect in rankings: reducing patient disability, alleviating pain, making illnesses more bearable, resolving uncertainty, and decreasing physical and emotional distress. These systems are justified by the fulfillment of their specific goals: to care, prevent, rehabilitate, and reassure.
  • Spain already has 40 CAR-T centers, reflecting the expansion of advanced therapies. The Ministry has published a report that takes stock of treatment with Advanced Therapies in 2025, with five new centers and 2,742 applications processed since 2019.

Companies

  • International
    • According to Elon Musk, there will be no nursing homes in the future; he claims his robots will be able to protect and care for the elderly. He proposes his humanoid robots as a solution to the shortage of caregivers and the high cost of elder care.
    • The historic trade agreement between the US and India will boost pharmaceutical trade. The pact will gradually eliminate Indian tariffs on European medicines and seeks to strengthen supply chains in a context of geopolitical tensions.
  • National
    • GSK, Sanofi, and MSD are the companies receiving the most funding from the $1.7 billion mega-contract for vaccines.

Biomedicine

  • Dr. William Foege, a key figure in the global eradication of smallpox, has died. He was director of the US Centers for Disease Control and Prevention (CDC) in the late 1970s and early 1980s (https://www.elmundo.es/ciencia-y-salud/salud/2026/01/26/697716f8fc6c8310558b4572.html)
  • AlphaGenome, a Google AI, predicts the impact of variations in DNA. This tool could be used to obtain more information about genetic diseases, improve genetic testing, and contribute to the development of new treatments (https://www.diariomedico.com/medicina/genetica/alphagenome-ia-google-predice-impacto-variaciones-adn.html). Original article in the journal Nature: https://www.nature.com/articles/s41586-025-10014-0
  • The surprisingly good results of just a little exercise. Exercise snacks and other forms of daily movement may help reduce the risk of death from heart disease (https://www.nature.com/articles/d41586-026-00237-0)
  • Scientists link 22 genes to common viral risks. Scientists have identified these genes, which explain how many people are at risk of life-threatening illnesses (https://www.ft.com/content/815dd3d9-f83b-448d-af52-ca6da6c9cd03)
  • Ultrasound is being used to treat treatment-resistant depression. Deep brain stimulation could improve severe depression (https://www.lemonde.fr/sciences/article/2026/01/28/les-ultrasons-a-l-assaut-des-depressions-resistantes_6664406_1650684.html)
  • Genes control longevity, regardless of how healthy a lifestyle is. Your lifespan potential is written in your genes, according to a new study (https://www.nytimes.com/2026/01/29/health/longevity-lifespan-age-genes.html). Access the original article in Science: https://www.science.org/doi/10.1126/science.adz1187
  • Mariano Barbacid cures pancreatic tumors in rats with a combination of three drugs. The Spanish researcher estimates that the first human trials will begin in three years and will require an investment of 30 million euros (https://www.abc.es/salud/enfermedades/mariano-barbacid-consigue-curar-tumores-pancreas-animales-20260127135426-nt.html)
  • AI improves mammogram readings: it detects more tumors, especially the most aggressive ones, and reduces those that went unnoticed. A Swedish clinical trial with more than 100,000 women shows that AI in mammographic screening detects more relevant cancers and reduces interval tumors by 12% without increasing false positives (https://www.elmundo.es/ciencia-y-salud/salud/2026/01/30/697b9345e4d4d8fb578b458d.html)

Global Health

  • The BMJ’s call: hospitals should be sanctuaries, not military targets (https://www.bmj.com/content/392/bmj.s115?nbd_source=adestra&nbd=8fbb67008476fb2494c9dc673c1a59b833545ade97e59cd7efd9c117443308b8&uaa_id=8fbb67008476fb2494c9dc673c1a59b833545ade97e59cd7efd9c117443308b8&utm_campaign=This%20week%20in%20The%20BMJ%20-%20Fortnightly%20manual%20alert&utm_medium=email&utm_source=adestra)
  • Infections are rampant in Sudan’s fields (https://www.bmj.com/content/392/bmj.s87?nbd_source=adestra&nbd=8fbb67008476fb2494c9dc673c1a59b833545ade97e59cd7efd9c117443308b8&uaa_id=8fbb67008476fb2494c9dc673c1a59b833545ade97e59cd7efd9c117443308b8&utm_campaign=This%20week%20in%20The%20BMJ%20-%20Fortnightly%20manual%20alert&utm_medium=email&utm_source=adestra)
  • The humanitarian situation in Yemen will worsen in 2026. A civil war The fact that this pandemic has already lasted 11 years will contribute to the proliferation of infectious diseases, malnutrition, and maternal mortality (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00196-0/fulltext)
  • How to eat well and within Earth’s limits. The impact of RFK Jr.’s new recommendations, which call for increased protein, fruit, and vegetable consumption, is being discussed (https://www.nature.com/articles/d41586-026-00236-1)
  • The number of people living in extreme heat by 2050 will double if temperatures rise by 2°C. Scientists believe that 41% of the population will experience these temperatures, with no part of the world immune (https://www.theguardian.com/environment/2026/jan/26/number-of-people-living-in-extreme-heat-to-double-by-2050-if-2c-rise-occurs-study-finds)

International Health Policy

  • USA
    • American medical groups will go to court to stop RFK Jr.’s vaccine changes. A coalition of doctors and public health advocacy groups will file a legal motion to halt the changes to the vaccination schedule. From RFK, Jr. (https://www.bmj.com/content/392/bmj.s145?nbd_source=adestra&nbd=8fbb67008476fb2494c9dc673c1a59b833545ade97e59cd7efd9c117443308b8&uaa_id=8fbb67008476fb2494c9dc673c1a59b833545ade97e59cd7efd9c117443308b8&utm_campaign=This%20week%20in%20The%20BMJ%20-%20Fortnightly%20manual%20alert&utm_medium=email&utm_source=adestra)
    • The United States says it will soon leave the WHO and that it will not pay the outstanding dues (https://www.elespanol.com/ciencia/salud/20260123/eeuu-anuncia-salida-efectiva-organizacion-mundial-salud-oms-insiste-no-pagara-cuotas-pendientes/1003744100610_0.html)
    • Trump’s proposals lead to Medicare austerity, offering an increase of less than 1%, which does not satisfy the hopes of insurers (https://www.politico.com/news/2026/01/28/trump-proposal-signals-medicare-austerity-00751365)
    • After donations, the Trump Administration revokes the order that required more staff in nursing homes. According to the New York Times, executives from those companies met with Trump, made a significant donation, and the project was withdrawn (https://www.nytimes.com/2026/01/27/us/politics/after-donations-trump-administration-revoked-rule-requiring-more-nursing-home-staff.html)
    • The psychedelic revolution that never happened. Although RFK, Jr. said at the time that he was going to promote them for mental disorders, that push never materialized (https://www.politico.com/news/2026/01/28/rfk-psychedelics-medicine-veterans-mdma-ptsd-00750414)
  • China
    • China is changing the rules in biotech. For over 100 years, the USA was the undisputed leader in biomedical research and innovation. China’s major advances put the US at risk of losing that position (https://www.science.org/doi/10.1126/science.aef7757)
  • India
    • India alerts over a deadly Nipah outbreak as other countries tighten controls. Indian health authorities are working against the clock to contain a new cluster of the Nipah virus detected in West Bengal, in the east of the country, after five infections were confirmed and around one hundred people were preventively isolated. (https://www.elmundo.es/ciencia-y-salud/salud/2026/01/26/69778d53e85eceda378b459e-video.html)
  • United Kingdom
    • Home births: Several trusts have to urgently review their services after the death of a mother and baby (https://www.bmj.com/content/392/bmj.s137?nbd_source=adestra&nbd=8fbb67008476fb2494c9dc673c1a59b833545ade97e59cd7efd9c117443308b8&uaa_id=8fbb67008476fb2494c9dc673c1a59b833545ade97e59cd7efd9c117443308b8&utm_campaign=This%20week%20in%20The%20BMJ%20-%20Fortnightly%20manual%20alert&utm_medium=email&utm_source=adestra)
    • According to the Prime Minister, the drop in vaccinations in the UK is a “national disgrace.” The vaccination strategy in England is slowing down (https://www.bmj.com/content/392/bmj.s139?nbd_source=adestra&nbd=8fbb67008476fb2494c9dc673c1a59b833545ade97e59cd7efd9c117443308b8&uaa_id=8fbb67008476fb2494c9dc673c1a59b833545ade97e59cd7efd9c117443308b8&utm_campaign=This%20week%20in%20The%20BMJ%20-%20Fortnightly%20manual%20alert&utm_medium=email&utm_source=adestra)
  • France
    • The Senate rejects The law on end-of-life issues is rejected and sent back to Congress (https://www.lemonde.fr/societe/article/2026/01/28/fin-de-vie-le-senat-rejette-la-loi-sur-l-aide-a-mourir-renvoyee-a-l-assemblee_6664474_3225.html)
    • The tense relations between liberal doctors and the Government. Several demonstrations against the regulation of liberal practice (https://www.lemonde.fr/idees/article/2026/01/27/entre-les-medecins-liberaux-et-l-etat-une-relation-sous-tension-au-risque-de-l-immobilisme_6664316_3232.html)
    • Medical deserts: the government willing to facilitate teleconsultations, currently limited to 20% (https://www.lemonde.fr/societe/article/2026/01/26/deserts-medicaux-le-gouvernement-desserre-un-peu-la-vis-sur-la-teleconsultation_6664220_3224.html)
  • Colombia
    • How politics destroyed a healthcare system model. For the past two decades, Colombia’s healthcare system was seen as a model for the rest of Latin America, both by the WHO and the World Bank. None of this changed President Petro’s mind, and he is trying to impose a change. radical(https://www.bmj.com/content/392/bmj.s76?nbd_source=adestra&nbd=8fbb67008 476fb2494c9dc673c1a59b833545ade97e59cd7efd9c117443308b8&uaa_id=8fbb67008476fb249 4c9dc673c1a59b833545ade97e59cd7efd9c117443308b8&utm_campaign=This%20week%20in%20The%20BMJ%20-%20Fortnightly%20manual%20alert&utm_medium=email&utm_source=adestra)

National Health Policy

  • Central Government Initiatives
    • The Health Data Space is born, a “step forward” in the transformation of the National Health System. The Minister of Health, Mónica García, closed the 1st National Meeting on Data Spaces, where the creation of the National Health Data Space (ENDS) was announced (https://www.consalud.es/politica/ministerio-sanidad/nace-el-espacio-nacional-de-datos-de-salud-un-paso-adelante-en-la-transformacion-del-sns.html)
    • The State Consortium for Advanced Therapies will have its administrative headquarters in Majadahonda and its scientific headquarters in Barcelona (https://www.diariomedico.com/medicina/politica/consorcio-estatal-terapias-avanzadas-tendra-sede-administrativa-majadahonda-cientifica-barcelona.html)
    • The Veo Plan has already received 54,000 applications since its implementation https://www.consalud.es/politica/ministerio-sanidad/el-plan-veo-ha-recibido-mas-de-54000-solicitudes-desde-su-implementacion.html)
  • Initiatives of the autonomous communities
    • The Galician Health Service (SERGAS) will integrate AI for the massive analysis of 1.8 million clinical images. Galicia promotes the early detection of diseases such as cancer and diabetes through the deployment of intelligent algorithms, the complete digitization of operating rooms, and an electronic health record accessible to all professionals (https://gacetamedica.com/politica/galicia-inteligencia-artificial-imagenes-sergas/)
    • The second phase of the Xenoma Galicia project begins, with 5,000 more tests (https://www.redaccionmedica.com/autonomias/galicia/comienza-la-segunda-fase-del-proyecto-xenoma-galicia-con-5-000-pruebas-mas-3482)
    • Madrid denounces the “irregular” assignment of the scientific direction of the CERTERA project to Catalonia (https://www.consalud.es/autonomias/c-madrid/madrid-denuncia-irregularidades-en-la-asignado-a-cataluna-de-la-direccion-cientifica-del-certera.html)
    • Healthcare The Basque Health Service admits it mistakenly administered expired vaccines to 253 people, mostly babies (https://elpais.com/sociedad/2026-01-27/la-sanidad-vasca-administra-por-error-vacunas-caducadas-a-253-personas-la-mayoria-bebes.html)
    • La Rioja strengthens research with €12.8 million (https://www.consalud.es/autonomias/la-rioja/la-rioja-reforzara-la-investigacion-y-la-innovacion-sanitaria-con-una-inversion-de-hasta-1286-millones-de-euros.html)
  • Framework Statute
    • Health Ministry signs agreement with unions on the Framework Statute, but without the support of doctors (https://elpais.com/sociedad/2026-01-26/sanidad-firma-un-acuerdo-para-el-nuevo-estatuto-marco-sin-el-apoyo-de-los-sindicatos-medicos.html)
    • Doctors aim to stop the Framework Statute and will take legal action in the European Parliament (https://www.elespanol.com/invertia/observatorios/sanidad/20260130/medicos-aspiran-frenar-estatuto-marco-cortes-emprenderan-acciones-legales-parlamento-europeo/1003744109202_0.html)
    • Vox takes the demand for a Framework Statute to Congress, the Senate, and the Autonomous Communities (https://www.consalud.es/politica/vox-lleva-la-demanda-de-un-estatuto-medico-hasta-el-congreso-senado-y-ccaa.html)
  • FUNCAS
    • A book by FUNCAS questions the (or not) deeply rooted myths about the Spanish public healthcare system. Whether we have the best healthcare system in the world, whether there is a shortage of doctors in Spain, or whether there really is a shortage of 100,000 nurses, are among the topics analyzed (https://diariofarma.com/2026/01/28/un-libro-de-funcas-cuestiona-bulos-o-no-arraigados-sobre-la-sanidad-publica-espanola)
  • CAR T-cell therapy centers
    • Spain now has 40 CAR T-cell therapy centers, reflecting the expansion of advanced therapies. The Ministry has published a report taking stock of Advanced Therapies treatment in 2025, with five new centers and 2,742 applications processed since 2019 (https://gacetamedica.com/politica/40-centros-car-t-terapias-avanzadas/)

Companies

  • International
    • AstraZeneca reaches a $4.7 billion agreement with China to boost obesity drugs (https://www.ft.com/content/c919380d-3f08-4dde-98e2-64e50b7da293)
    • The historic trade agreement between the US and India will boost pharmaceutical trade. The pact will gradually eliminate Indian tariffs on European medicines and seeks to strengthen supply chains in a context of geopolitical tensions.(https://www.consalud.es/salud35/internacional/la-ue-e-india-sellan-un-historico-acuerdo-de-libre-comercio-que-impulsa-el-intercambio-farmaceutico.html)
    • According to Elon Musk, there will be no nursing homes in the future; he claims his robots will be able to protect and care for the elderly. Musk proposes its humanoid robots as a solution to the shortage of caregivers and the high cost of elderly care (https://www.eleconomista.es/tecnologia/noticias/13752514/01/26/en-el-futuro-no-habra-residencias-musk-asegura-que-sus-robots-con-ia-seran-increibles-para-proteger-y-cuidar-a-las-personas-mayores.html)
    • Bayer begins to see the light at the end of the tunnel, moving away from litigation and focused on its business (https://cincodias.elpais.com/mercados-financieros/2026-02-01/bayer-comienza-a-ver-la-luz-a-final-del-tunel-alejada-de-litigios-y-centrada-en-el-negocio.html)

7 days in healthcare (January 19th-25th, 2026)

 

Summary

The most impactful healthcare news of the week included:

  • Biomedicine: AI trends in healthcare in 2026 analyzed.
  • Global health: Venezuelan doctors speak out and denounce the situation in the healthcare sector.
  • International health policy: The UK’s good idea for customized genetic medicines, proposing a new reimbursement system.
  • National health policy: Doctors increase pressure on the Health Ministry and call for a week-long strike each month until June.
  • Business: “Big Tobacco” companies are evolving into “Big Nicotine”.

Biomedicine

  • AI trends in healthcare in 2026. The trends that seem clear and very positive, according to Bertalan Mesko, are: 1. Language models; 2. Home blood collection; 3. An improvement in longevity, integrating this approach into our daily lives; 4. Healthcare navigation systems; 5. The beginning of heart rate variability analysis; 6. The year of the consolidation of “scribes” in consultations; 7. Generative artificial intelligence for pharmaceutical companies.
  • The treatment of a teenager with an ultra-rare disease as a medical milestone. The possibilities of CRISPR technology in these types of diseases.
  • Scientists create a scalpel that provides instant data during surgeries. Researchers at the Institute of Chemical Technology in Prague (UCT Prague) have developed and validated the “laboratory in a scalpel” concept.

Global Health

  • Venezuelan doctors speak out. Doctors denounce the ongoing repression and the multiple failures of the health system, as medicines are scarce and very expensive, waiting lists grow endlessly, and the exodus of doctors is constant.
  • “Made in Africa” ​​laboratories to detect epidemics in record time. The Pasteur Institute in Dakar is leading a project to monitor the emergence of diseases such as Ebola, dengue fever, and yellow fever in more than a dozen countries. They are seeking a faster response time and to reduce dependence on foreign aid.

International Health Policy

  • The UK’s good idea for customized genetic medicines. The UK is testing a new funding system for these medicines, not based, as is customary, on sales volume. Only with a different reimbursement system will it be possible to develop medicines for ultra-rare diseases.
  • Trump’s second term and the weaponization of healthcare. This article lists all of Trump’s attacks on the healthcare system.
  • Much more land would be needed to comply with the red meat-rich diet proposed by RFK, Jr. The 25% increase in meat and dairy products would require 100 million more acres of land for agriculture.

National Health Policy (Spain)

  • Doctors increase pressure on the Health Ministry and call for a week-long strike each month until June. The first strike will begin on February 16th, and the unions are calling for a “united demonstration” two days prior in Madrid. The Secretary General of CESM, in response to the proposed indefinite strike, reiterates the demand for a medical statute similar to those in Portugal, the United Kingdom, and Germany.

Companies

  • International
    • “Big Tobacco” companies are evolving into “Big Nicotine.” Companies such as British American Tobacco and Philip Morris are reorienting their businesses toward nicotine-based alternatives.
    • Trump’s attacks on the pharmaceutical industry are driving increased interest from funds in this sector in Europe. The value of private equity transactions in Europe has increased by 70%, while in the United States it has grown by only 20%.
  • National
    • The health insurance sector once again stands out above the rest of the insurance industry and is projected to grow by 11.43% in 2025. Health insurance premiums totaled €13.443 billion, and among its varieties—healthcare assistance, reimbursement, and subsidy—the first stands out, having grown by 12.08%.

Biomedicine

  • A new study highlights the brain’s role in the immune system. This is demonstrated in a study with volunteers conducted in Israel and published in Nature Medicine (https://www.economist.com/science-and-technology/2026/01/21/a-new-study-highlights-the-brains-role-in-immune-health)
  • Blood biomarkers for Alzheimer’s. These tests are cost-effective, minimally invasive, and highly accessible (https://doi.org/10.1001/jama.226049)
  • AI trends in healthcare in 2026. The trends that appear clear and very positive, according to Bertalan Mesko, are: 1. Language models; 2. Home blood collection; 3. An improvement in longevity by integrating the approach into our daily lives; 4. Healthcare navigation systems; 5. The beginning of heart rate variability analysis; 6. The year of the consolidation of “scribes” in consultations; 7. Generative artificial intelligence for pharmaceutical companies (https://medicalfuturist.com/top-digital-health-and-healthcare-ai-trends-to-watch-in-2026)
  • Treating a teenager with an ultra-rare disease as a medical milestone. The possibilities of CRISPR technology in these types of diseases (https://www.economcom/science-and-technology/2026/01/19/treatment-of-a-teenager-with-an-ultra-rare-condition-is-a-medical-milestone)
  • Some immune systems defeat cancer: a possible drug? Researchers found an antibody that appears to play a role in people with a better prognosis for lung cancer. But translating that into a drug can be difficult (https://www.nytimecom/2026/01/22/health/lung-cancer-antibodies-immune-system.html)
  • How air pollution impacts ALS risk. A study finds that pollution also accelerates the progression of amyotrophic lateral sclerosis (https://www.abc.es/salud/enfermedades/relacion-contaminacion-aire-mayor-riesgo-ela-20260121145800-nt.html)
  • The baby saved with CRISPR and four other scientific milestones in 2025 (https://elpais.com/expres/2025-12-09/el-bebe-salvado-con-crispr-y-otros-cuatro-hitos-de-la-ciencia-en-2025.html)
  • Genetic variants identified that explain why 15% of pregnancies end in miscarriage. A study of 140,000 embryos shows with unprecedented detail how less than half of human conceptions survive to birth (https://www.abc.es/salud/enfermedades/explican-embarazos-terminan-abortos-espontaneos-20260121170023-nt.html)
  • The bacteria that causes syphilis was already present in the Americas 5,500 years ago (https://elpais.com/ciencia/2026-01-22/la-bacteria-causante-de-la-sifilis-ya-estaba-en-america-hace-5500-anos.html). Access the original article: https://www.science.org/doi/10.1126/science.adw3020
  • A large study rules out that drugs like omeprazole increase the risk of stomach cancer, as suggested by previous studies (https://www.ecom/directivos/estilo-vida/salud/2026/01/22/6970b2fde5fdead8798b4577.html). Access the original article: https://www.bmj.com/content/392/bmj-2025-086384
  • Scientists create a scalpel that provides instant data during surgery. Researchers at the Institute of Chemical Technology in Prague (UCT Prague) have developed and validated the concept of a “scalpel-like laboratory” (https://www.consalud.es/saludigital/innovacion-tecnologica/disenan-un-bisturi-que-permite-obtener-informacion-sobre-la-cirugia-en-tiempo-real.html)

Global Health

  • To properly assess progress in global health, high-quality evidence is needed (https://www.nature.com/articles/d41586-026-00073-2). To this end, the journal Nature has published a new article titled Nature Health, specifically to measure the correlation between policy and practice.
  • Sudan: Infectious diseases are on the rise in rural areas (https://www.bmj.com/content/392/bmj.s87)
  • Venezuelan doctors are speaking out. Doctors report that repression continues and the healthcare system suffers from multiple failures, with medicines scarce and prohibitively expensive, waiting lists constantly growing, and a steady exodus of doctors (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00134-0/fulltext).
  • Bill Gates and OpenAI contribute $50 million to expand AI use in African clinics. They hope to bring AI to more than 1,000 clinics in Rwanda and other African countries, with the aim of expanding access to quality healthcare in poor countries (https://www.ft.com/content/94e685da-f41d-4625-8585-768d7f901c35)
  • Microplastics are no longer a public health emergency in Africa, according to the African Union Health Agency (https://www.lemonde.fr/afrique/article/2026/01/24/la-mpox-n-est-plus-une-urgence-de-sante-publique-en-afrique-annonce-l-agence-de-sante-de-l-union-africaine_6663944_3212.html)
  • Is the threat of microplastics really that serious? The problem is real, but several studies claim that the figures are inflated. A study published in Nature concludes that estimates of their presence in the air could be exaggerated by between 100 and 10,000 times (https://elpais.com/clima-y-medio-ambiente/2026-01-21/es-tan-grave-la-amenaza-de-los-microplasticos-el-problema-es-real-pero-varias-investigaciones-denuncian-que-las-cifras-estan-infladas.html). Access the original article: https://www.nature.com/articles/s41586-025-09998-6
  • “Made in Africa” laboratories to detect epidemics in record time. The Pasteur Institute in Dakar is leading a project to monitor the emergence of diseases such as Ebola, dengue fever, and yellow fever in more than a dozen countries. They are seeking a faster response time and to reduce dependence on foreign countries (https://elpais.com/planeta-futuro/2025-12-02/laboratorios-made-in-africa-para-detectar-epidemias-en-tiempo-record.html)

International Health Policy

  • USA
    • Trump’s second term and the weaponization of healthcare. This article lists all of Trump’s attacks on the healthcare system (https://www.bmj.com/lookup/doi/10.1136/bmj.s91)
    • The US’s return to the WHO may depend on Trump’s ability to impose his new director, as the position is up for renewal next year. According to Politico, the US’s return will depend on whether Trump likes the new director (https://www.politico.com/news/2026/01/22/who-world-health-organization-trump-tedros-00740545)
    • Much more land would be needed to comply with the high-red-meat diet proposed by RFK, Jr. The 25% increase in meat and dairy products would require 100 million more acres of land for agriculture (https://www.theguardian.com/environment/2026/jan/20/rfk-jr-trump-meat-diet-guidelines-land)
    • Republicans will face intense pressure to support Trump’s healthcare plan. A lack of Democratic support would mean the plan would not pass the Senate under current rules (https://www.politico.com/news/2026/01/20/trump-health-plan-congress-00734445)
    • Kennedy’s anti-vaccine policy unites Democrats and Republicans against him. The Health Secretary appeared before the Senate after firing the director of the Centers for Disease Control and Prevention over disagreements about vaccines (https://elpais.com/sociedad/2025-09-04/la-politica-antivacunas-de-kennedy-une-a-democratas-y-republicanos-en-su-contra.html)
    • Big insurers try to blame hospitals and the pharmaceutical industry for the increase in healthcare spending in the USA. In two appearances before Congress, the executives were accused of failing to control healthcare spending (https://www.nytimes.com/2026/01/22/health/health-insurers-obamacare-congress.html)
  • China
    • China’s birth rate plunges to its lowest level since 1949. China’s population has declined for four consecutive years (https://www.nytimes.com/2026/01/18/business/china-population-data.html)
  • India
    • Advances in healthcare, India’s ambitions. It aims to become a developed nation by 2047 (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02636-4/fulltext)
  • United Kingdom
    • The UK’s good idea for customized genetic medicines. The UK is testing a new funding system for these medicines, not based, as is usual, on sales volume (https://www.economist.com/leaders/2026/01/22/britains-good-idea-for-custom-genetic-medicines)
    • NHS regions should be part of the NHS, not the Department (https://www.kingsfund.org.uk/insight-and-analysis/blogs/nhs-regions-department)
    • The Nuffield Trust’s response to the NHS’s online hospitals proposal. The article proposes that the seven regions become health authorities, rather than relying solely on the Ministry (https://www.nuffieldtrust.org.uk/news-item/nuffield-trust-response-to-plans-set-out-for-nhs-online-hospital)
    • Health insurers are growing at a record pace, among the problems facing the NHS, particularly due to insurance companies offering plans to their employees, given the difficulty of accessing the public system (https://www.ft.com/content/ef58761a-bf03-4eef-8a89-f31e193e51f7)

National Health Policy

  • Central Government Initiatives
    • From Funding Medicines to Funding Indications: A Silent Shift in the NHS. Analysis of public funding for medicines reveals a profound shift in the NHS: decisions are not being reduced, but their scope is. Total funding for authorized indications has been steadily declining in recent years. (https://diariofarma.com/2026/01/20/de-financiar-medicamentos-a-financiar-indicaciones-asi-es-el-giro-silencioso-del-sns)
  • Regional Government Initiatives
    • The Ayuso government imposes fines on 7 public/private hospitals for failing to meet quality standards. EL PAÍS has obtained internal documents showing that €2.2 million was not paid to hospitals between 2021 and 2024 due to maintenance or laundry failures (https://elpais.com/espana/madrid/2026-01-22/el-gobierno-de-ayuso-impone-multas-a-siete-hospitales-publico-privados-por-incumplir-los-estandares-de-calidad.html)
    • Valencian Community: the “new” primary care is launched (https://www.diariomedico.com/medicina/medicina-familiar/comunidad-valenciana-nueva-atencion-primaria-ve-luz.html)
    • The Basque Country launches a pioneering model that unites doctors and social services in a single space (https://www.consalud.es/autonomias/pais-vasco/el-pais-vasco-estrena-un-modelo-pionero-que-une-medicos-y-servicios-sociales-en-un-solo-espacio.html)
    • The new Faculty of Medicine arrives in La Rioja (https://www.consalud.es/autonomias/la-rioja/la-nueva-facultad-de-medicina-llega-este-2026-a-la-rioja-nuestro-ecosistema-sanitariose-va-a-fortalecer.html)
    • Osakidetza awards 60 hard-to-fill family doctor positions (https://www.redaccionmedica.com/autonomias/pais-vasco/osakidetza-adjudica-60-plazas-de-dificil-cobertura-a-medicos-de-familia–6471)
  • MIR (Medical Residency Exam)
    • A chaotic MIR exam begins (https://www.elconfidencial.com/salud/2026-01-21/mir-2026-que-es-preguntas_4287426/)
    • Nearly 800 unsuccessful applicants will be able to take the exam (https://www.elmundo.es/ciencia-y-salud/salud/2026/01/24/6973a8bd21efa05a4c8b45d8.html)
  • Framework Statute
    • Doctors increase pressure on the Health Ministry and call for a week-long strike each month until June. The first strike will begin on February 16, and the unions are calling for a “united demonstration” two days prior in Madrid (https://elpais.com/sociedad/2026-01-22/los-medicos-convocan-una-semana-de-huelga-al-mes-desde-el-16-de-febrero-para-exigir-un-estatuto-propio.html)
    • “The European medical profession has its own statutes, so why is Spain the exception?” The Secretary General of CESM, in response to the proposed indefinite strike, reiterates the demand for a medical statute like those in Portugal, the United Kingdom, and Germany. (https://www.diariomedico.com/medicina/profesion/profesion-medica-europea-estatutos-propios-espana-excepcion.html)
  • Artificial intelligence
    • 90% of young people use AI for health consultations before going to the doctor. One in four Spaniards admits to self-diagnosing via the internet, influencers, or AI tools (https://theobjective.com/sanidad/2026-01-25/jovenes-ia-consultas-salud-medico/)
  • Medical Negligence
    • Complaints of medical negligence are skyrocketing in Spain (https://www.elespanol.com/ciencia/salud/20260121/denuncias-negligencia-medica-disparan-espana-crecen-cirugias-esteticas-fallidas-partos-hipoxia/1003744097141_0.html)

Companies

  • International
    • “Big Tobacco” companies are evolving into “Big Nicotine.” Companies like British American Tobacco and Philip Morris are refocusing their businesses on nicotine-based alternatives (https://www.ft.com/content/701f58d2-66f8-4dfb-91de-f49dadecc24e)
    • GSK poised to acquire a food allergy company for $2.2 billion (https://www.ft.com/content/80a5f5fc-59e0-4969-803e-7fd50e4812ba)
    • Trump’s attacks on the pharmaceutical industry are driving increased interest from funds in this sector in Europe. The value of private equity deals in the old continent has risen by 70%, while in the United States it has grown by ‘only’ 20%. (https://www.elespanol.com/invertia/observatorios/sanidad/20260121/ataques-trump-industria-farmaceutica-disparan-interes-fondos-sector-europa/1003744097200_0.html)
    • Abbvie also agrees to price reductions with the Trump Administration (https://www.diariomedico.com/medicina/empresas/abbvie-acuerda-tambien-bajadas-precios-administracion-trump.html)
  • National News
    • The gym business in Spain gains strength in 2025 (https://theobjective.com/economia/2026-01-24/gimnasios-espana-facturacion-2025/)
    • The health insurance sector once again stands out above the rest of the insurance industry and grows by 11.43% in 2025. Health insurance premiums totaled €13.443 billion, and among its varieties—healthcare, reimbursement, and subsidy—the first stands out, having grown by 12.08%. (https://www.diariomedico.com/medicina/empresas/ramo-salud-vuelve-destacar-resto-seguros-crece-1143-2025.html)
    • Miranza reinforces its leadership in ophthalmology with the incorporation of the Bedia clinic in Cantabria (https://www.consalud.es/salud35/nacional/miranza-refuerza-su-liderazgo-en-oftalmologia-con-la-incorporacion-de-clinica-bedia-en-cantabria.html)
    • Sanitas strengthens its healthcare network with a new comprehensive medical center in Alicante by 2027 (https://www.consalud.es/salud35/nacional/sanitas-refuerza-su-red-asistencial-con-un-nuevo-centro-medico-integral-en-alicante-para-2027.html)
    • Galenicum partners with India’s Lupin to manufacture generics of Ozempic (https://www.expansion.com/catalunya/2026/01/23/69727d31e5fdea8f688b458e.html)
    • HM will build a mega-hospital complex in northern Madrid. The Abarca family’s new complex will consist of a hospital, a senior living residence, and a university campus. (https://www.eleconomista.es/salud-bienestar/noticias/13739177/01/26/hm-hospitales-construira-un-megacomplejo-sanitario-en-el-norte-de-madrid.html)
    • Sanofi will transfer the management of its factory in Girona to Adamed Pharma) (https://www.eleconomista.es/salud-bienestar/noticias/13739448/01/26/sanofi-transferira-la-gestion-de-su-fabrica-en-girona-a-adamed-pharma.html)

7 days in healthcare (January 12th-18th, 2026)

 

Summary

The week’s most impactful health news stories were:

  • Biomedicine: The trap of “miracle” weight-loss drugs: the rebound effect is faster than with conventional diets.
  • Global health: The Lancet Commission on improving post-COVID health finds that international agreements are failing to reduce three closely linked health threats.
  • International health policy: Trump unveils the new health plan, albeit with few details (the entire plan is a single sheet of paper).
  • National health policy: Pensions and public healthcare at risk for the first time in Spain, according to Davos.
  • Business: A generic Ozempic for €15 a month, or how to revolutionize the obesity drug market.

Biomedicine

  • The trap of “miracle” weight-loss drugs: the rebound effect is faster than with conventional diets. An analysis of 37 studies reveals the hidden side of GLP-1 agonists: the large-scale study shows that weight returns in less than two years.
  • Predicting type 2 diabetes risk from a drop of blood. A study identifies a blood signature that better predicts the risk of type 2 diabetes.
  • A vaccine to prevent colon cancer shows promising results. The preventive immunization Nous-209 works in an initial trial with patients who have 17 times the risk of developing tumors compared to the general population.
  • Seven biomarkers can reveal the risk of multimorbidity through a blood test. A study from the Karolinska Institute asserts that “altered metabolism, stress responses, and energy regulation are among the main drivers of multimorbidity in older adults.”

Global Health

  • The Lancet commission on improving post-COVID health. A large number of international agreements are failing to reduce three closely linked threats: non-communicable diseases, infectious disease outbreaks, and environmental degradation.

International Health Policy

  • Trump unveils the new health plan, albeit with few details. The plan’s key elements are lower drug prices and “personal savings accounts” to give money to citizens, rather than to insurance companies. The new plan is only one page long. After so many announcements, more specific proposals could have been considered.
  • National health spending in the USA rose (7.2%) for the second consecutive year in 2024. Hospital costs and medications are the components of spending that have increased the most. The insured population was 91.8% in 2024, up from 92.5% in 2023. Healthcare spending grew faster than the overall economy, rising from 17.7% of GDP in 2024 to 18% in 2025.
  • The new US food pyramid: a step backward that benefits the industry. The pseudoscientist Robert F. Kennedy Jr. has inverted the food pyramid to promote red meat and other animal proteins.
  • The improvement in research in China: a global opportunity. It is the most productive nation in terms of scientific publications.
  • The WHO warns that low taxes on alcohol and sugary drinks increase health risks and calls on governments to raise and update taxation to fund healthcare.
  • HERA (the EU’s Health Emergency Preparedness and Response Authority) prioritizes the assessment of EU health threats in four areas: respiratory viruses, animal transmission, AMR (adverse drug reactions), and armed conflict.

National Health Policy (Spain)

  • Pensions and public healthcare are at risk for the first time in Spain, according to Davos. The World Economic Forum’s Global Risks report identifies “insufficient public services, such as social protection, education, infrastructure, and pensions” as among Spain’s greatest risks. This is a major setback for the Sánchez government, which boasts of protecting and improving public services.
  • The Ministry of Health will not meet with doctors and rules out a future agreement: “What they are asking for is impossible.” This attitude is absolutely intolerable. What doctors are asking for is a specific statute, that is, a way to guarantee a certain degree of “medical leadership” in healthcare, which is necessary. Without undervaluing teamwork and the contribution of other professionals, the doctor/patient relationship remains the core activity of any healthcare system.
  • Record competition for the MIR exam in 2026 will leave 7,487 applicants without a residency position. This is a good way to replicate the problem of “leftovers” (proliferation of doctors without a specialty), which affected the system a few years ago.

Companies

  • International
    • A generic Ozempic for €15 a month: how to revolutionize the obesity drug market. This is because the patents for semaglutide, the key ingredient in Ozempic and the Wegovy weight-loss brand, are beginning to expire worldwide.
  • National
    • Rob Surgical will invest €50 million and open its surgical robot plant in El Prat. Bitrack, the first surgical robot designed and manufactured in Catalonia, is moving towards the market.

Biomedicine

  • The Lancet study finds no increased risk of autism when pregnant women take paracetamol. Trump’s claims that women who take paracetamol during pregnancy are at risk of having children with autism are not supported by any evidence, according to The Lancet (https://www.ft.com/content/18ac00eb-0ab4-478c-9a5b-e4c4c5b47d1c). Access the original article: https://www.thelancet.com/journals/lanogw/article/PIIS3050-5038(25)00211-0/fulltext
  • Research: The Fleming Initiative. An Imperial College project seeking a solution to bacterial resistance to antibiotics (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00087-5/abstract)
  • Most cases of Alzheimer’s are linked to a single gene. Although APOE is linked to Alzheimer’s, very few treatments in clinical trials directly target this gene (https://www.abc.es/salud/enfermedades/mayoria-casos-alzheimer-relacionados-variantes-solo-gen-20260109134521-nt.html).
  • The trap of “miracle” weight-loss drugs: the rebound effect is faster than with conventional diets. An analysis of 37 studies reveals the hidden side of GLP-1 agonists: the large-scale study shows that the weight returns in less than two years (https://elpcom/salud-y-bienestar/2026-01-07/la-trampa-de-los-medicamentos-milagro-para-adelgazar-el-efecto-rebote-es-mas-rapido-que-con-dietas-convencionales.html). Access the original article in the British Medical Journal: https://www.bmj.com/content/392/bmj-2025-085304
  • Predicting the risk of type 2 diabetes from a drop of blood. A study identifies a blood signature to better predict the risk of type 2 diabetes (https://www.abc.es/salud/enfermedades/predecir-riesgo-diabetes-tipo-partir-gota-sangre-20260114142504-nt.html)
  • Radiology and AI, natural allies? Hospitals using algorithms detect clinical cases better and faster, but to expand their use, it is still necessary to unify criteria and have healthcare systems capable of integrating them on a large scale (https://elpais.com/proyecto-tendencias/2025-12-10/radiologia-e-ia-aliadas-naturales-me-ayuda-a-no-pasar-por-alto-hallazgos-sutiles.html)
  • A vaccine to prevent colon cancer shows promising results. The preventive immunization Nous-209 works in an initial trial with patients who have 17 times the risk of developing tumors compared to the general population (https://elpais.com/ciencia/2026-01-16/una-vacuna-para-prevenir-el-cancer-de-colon-muestra-resultados-prometedores.html)
  • AI algorithm revolutionizes the reading of cancer biopsies in one minute. The SMMILe tool, tested on six types of cancer, allows for precise tumor mapping from basic data, accelerating diagnosis and bringing personalized treatment closer thanks to AI (https://www.consalud.es/saludigital/tecnologia-sanitaria/avances-en-ia-aceleran-el-analisis-del-cancer-un-algoritmo-reduce-a-un-minuto-la-lectura-de-biopsias.html)
  • AI outperforms radiologists in pancreatic cancer detection and promises early diagnoses. The system achieved 38% fewer false positives and 92% accuracy, according to a study with data from nearly 400 patients (https://www.consalud.es/saludigital/innovacion-tecnologica/un-modelo-de-ia-supera-a-radiologos-en-la-deteccion-del-cancer-de-pancreas-y-abre-la-puerta-a-diagnosticos-tempranos.html)
  • Seven biomarkers can reveal the risk of multimorbidity through a blood test. A study from the Karolinska Institute states that “alterations in metabolism, stress responses, and energy regulation are among the main drivers of multimorbidity in older adults” (https://diariofarma.com/2026/01/10/siete-biomarcadores-pueden-revelar-el-riesgo-de-multimorbilidad-a-traves-de-un-analisis-de-sangre). Original article in Nature: https://www.nature.com/articles/s41591-025-04038-2

Global Health

  • The ceasefire does little to improve the “horrific” situation in Gaza. Two new reports detail the harm suffered by women and children (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00086-3/fulltext)
  • The decline in smokeless tobacco (ST) use and oral cancer in a global perspective. ST is used by more than 360 million people and is classified as a Group 1 carcinogen by the International Agency for Research on Cancer (https://www.nejm.org/doi/full/10.1056/NEJMp2500631)
  • The Lancet’s commission on improving post-COVID health. A large number of international agreements are failing to reduce three closely linked threats: non-communicable diseases, outbreaks of infections, and environmental degradation (https://www.thelancet.com/action/showPdf?pii=S0140-6736%2825%2902061-6)

International Health Policy

  • USA
    • Trump unveils new health plan, albeit with few details. The oft-announced plan focuses on “personal savings accounts” and providing money to citizens, rather than to insurers (https://www.nytimes.com/2026/01/15/us/politics/trump-health-care-plan.html). Information on this topic according to Politico: https://www.politico.com/news/2026/01/15/trump-health-outline-00730933. Access to “The Great Healthcare Plan”—though it’s called “great,” the plan is just one sheet of paper: https://www.whitehouse.gov/wp-content/uploads/2026/01/The-Great-Healthcare-Plan.pdf
    • National health spending rose (7.2%) for the second consecutive year in 2024. Hospital and drug costs are the components of spending that have increased the most. The insured population was 91.8% in 2024, up from 92.5% in 2023 (https://www.politico.com/news/2026/01/14/national-health-spending-soars-in-2024-00728963). Access the original source in Health Affairs: https://www.healthaffairs.org/doi/full/10.1377/hlthaff.2025.01683
    • The new US food pyramid: a return to the past that benefits industry. Pseudoscientist Robert F. Kennedy Jr. has turned the food pyramid on its head to promote red meat and other animal proteins (https://elpais.com/salud-y-bienestar/2026-01-10/la-nueva-piramide-nutricional-de-ee-uu-una-vuelta-al-pasado-que-beneficia-a-la-industria.html)
    • The Trump Administration says some approved child vaccines need better studies, while scientists disagree (https://www.science.org/content/article/trump-administration-says-some-approved-childhood-vaccines-need-better-studies)
    • Trump announces withdrawal from 66 global organizations. On January 7, Trump signed an executive order announcing the withdrawal of a number of organizations, which he claims are contrary to U.S. interests (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00085-1/fulltext)
    • Abortion opponents threaten to withdraw their support in the midterm elections due to disagreements with Trump (https://www.politico.com/news/2026/01/15/abortion-opponents-revamp-their-midterms-plans-as-rift-with-trump-widens-00729224)
  • China
    • Upgrading research in China: a global opportunity. It is the most productive nation in terms of scientific publications (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00084-X/fulltext)
  • United Kingdom
    • The agreement with Trump on rising drug prices in the UK is a step backward, according to some experts (https://www.ft.com/content/4a903571-5ac7-44e4-b8b7-4191339748f2)
    • Keir Starmer announces greater restrictions on children’s access to social media, concerned about the excessive use of smartphones by children and teenagers (https://www.ft.com/content/d0d239f5-44cd-4c78-be08-ce55670e7808)
  • France
    • Liberal doctors suspend their strike after some government proposals and a promise to renew dialogue (https://lemonde.fr/societe/article/2026/01/16/les-medecins-liberaux-suspendent-leur-greve-annonce-un-syndicat_6662590_3224.html)
  • Japan
    • Japan and the lessons of a healthcare system in transformation, embracing aging and frailty (https://www.redaccionmedica.com/opinion/felix-rubial-7847/japon-y-las-lecciones-de-un-sistema-sanitario-en-transformacion-6031)
  • WHO
    • The WHO warns that low taxes on alcohol and sugary drinks increase health risks and calls on governments to raise and update taxation to finance the Health (https://elpais.com/salud-y-bienestar/2026-01-13/la-oms-alerta-de-que-los-bajos-impuestos-al-alcohol-y-a-las-bebidas-azucaradas-disparan-los-riesgos-para-la-salud.html)
  • European Union
    • The EU is missing the boat on healthcare AI. While Europe has become entangled in over-regulation that demands absolute guarantees before even beginning to experiment, other countries have opted for more flexible and adaptive approaches. (https://www.elespanol.com/opinion/tribunas/20260113/ue-perdiendo-tren-ia-sanitaria/1003744086257_12.html)
    • HERA (Health Emergency Preparedness and Response Authority) prioritizes the assessment of EU health threats in four areas: respiratory viruses, animal transmission, AMR (adverse drug reactions), and armed conflict. (https://diariofarmcom/2026/01/13/hera-prioriza-la-evaluacion-de-amenazas-sanitarias-de-la-ue-en-cuatro-areas)

National Health Policy

  • Impact of General Policy on Health
    • Pensions and public healthcare at risk for the first time in Spain, according to Davos. The World Economic Forum’s Global Risks report identifies “insufficient public services, such as social protection, education, infrastructure, and pensions” as among Spain’s greatest risks. This is a major setback for the Sánchez government, which boasts of protecting and improving public services (https://www.expansion.com/economia/politica/2026/01/14/69674b09468aeb53588b4593.html). Access the Global Risks Report 2026 (21st Edition): https://reports.weforum.org/docs/WEF_Global_Risks_Report_2026.pdf (page 89 lists the risks in Spain: 1. Social polarization; 2. Talent and worker shortages; 3. Inadequate public services and social protection (including education, infrastructure, pensions); 4. Debt (public, corporate, and household); and 5. Lack of economic opportunities and employment)
  • Central Government Initiatives
    • The Ministry of Health will take Ayuso to court for the lack of a registry of abortion conscientious objectors (https://elpais.com/sociedad/2026-01-16/sanidad-denuncia-al-gobierno-de-ayuso-por-no-tener-registro-de-objetores-del-aborto.html)
  • Autonomous Community Initiatives
    • Agreement on healthcare Asturian: 12-hour shifts, reduced appointment schedules in Primary Care, and fewer restrictions on combining public and private healthcare (https://www.diariomedico.com/medicina/profesion/acuerdo-sanidad-asturiana-guardias-flexibles-reduccion-agendas-ap.html)
    • The Valencian Community is preparing new support measures for rural pharmacies, with an emphasis on updating schedules, emergency care, and vacations, “improving work-life balance without compromising the continuity of pharmaceutical services to the public” (https://diariofarma.com/2026/01/15/comunidad-valenciana-prepara-nuevas-medidas-de-apoyo-y-flexibilidad-para-la-farmacia-rural)
    • Farmaindustria and the Catalan Government will promote Catalonia as a major biopharmaceutical hub (https://diariofarma.com/2026/01/15/farmaindustria-y-cataluna-potenciaran-la-region-como-un-gran-polo-biofarmaceutico)
    • The cities vying to host the AESAP: Zaragoza, Granada, Barcelona, ​​Oviedo, León, Murcia, Toledo, Lugo, and Salamanca (https://www.consalud.es/autonomias/las-nueve-ciudades-que-aspiran-a-sede-de-la-aesap-al-descubierto-cuales-son-sus-propuestas.html)
  • Transplants
    • Spain is nearing its all-time record for transplants and has been the world leader for 34 years. (https://elpais.com/sociedad/2026-01-16/espana-roza-su-record-historico-de-trasplantes-de-organos-y-encadena-34-anos-como-lider-mundial.html)
  • Framework Statute
    • The Ministry of Health will not meet with doctors and rules out a future agreement: “What they are asking for is impossible” (https://www.elespanol.com/invertia/observatorios/sanidad/20260116/ministerio-sanidad-no-reunira-medicos-descarta-futuro-acuerdo-piden-imposible/1003744091205_0.html)
  • MIR Exam
    • Medical outrage over the lack of transparency and the Ministry of Health’s poor management in organizing the MIR exam (https://www.larazon.es/sociedad/indignacion-medica-pesima-gestion-falta-transparencia-sanidad-examen-mir_202601126964594ebe7ae37724bfbfcd.html)
    • Record competition for the MIR exam in 2026 will leave 7,487 applicants without a residency position (https://www.elespanol.com/invertia/observatorios/sanidad/20260117/competencia-record-mir-dejara-sin-plaza-aspirantes-examen/1003744092787_0.html)

Companies

  • International
    • Nvidia and Microsoft support an AI breakthrough related to gene therapy. UK’s Basecamp Research uses genomic sequencing databases to address cancers and resistant bacteria (https://www.ft.com/content/29ec4303-cb70-48b5-a28c-320a7062cdd3)
    • From Lilly’s Orforglipron to Novo Nordisk’s CagriSema, the obesity drugs that will break the bank in 2026 (https://www.elespanol.com/invertia/observatorios/sanidad/20260115/orforglipron-lilly-cagrisema-novo-nordisk-farmacos-obesidad-romperan-banca/1003744089743_0.html)
    • 25% of the population would be candidates for GLP-1 treatment. Women and older people more frequently meet the eligibility criteria to receive these obesity drugs. (https://www.diariomedico.com/medicina/medicina-preventiva/25-poblacion-mundial-seria-candidata-tratamiento-glp-1.html)
    • The ten largest acquisitions in the pharmaceutical industry in 2025 (https://elglobalfarma.com/industria/diez-mayores-adquisiciones-industria-farmaceutica-2025/)
    • Johnson & Johnson, Novartis, and MSD lead the biggest acquisitions of 2025 (https://www.eleconomista.es/salud-bienestar/noticias/13722104/01/26/johnson-johnson-novartis-y-msd-lideran-las-mayores-compras-en-2025.html)
    • A generic Ozempic for 15 euros a month, or how to revolutionize the market Obesity drugs. This is because the patents for semaglutide, the key ingredient in Ozempic and the Wegovy weight-loss brand, are beginning to expire worldwide (https://cincodias.elpais.com/companias/2026-01-15/un-ozempic-generico-a-15-euros-al-mes-o-como-revolucionar-el-mercado-de-farmacos-para-la-obesidad.html)
  • National News
    • The government will require health insurers to have a viability plan (https://www.redaccionmedica.com/secciones/privada/el-gobierno-obligara-a-las-aseguradoras-de-salud-a-tener-plan-de-viabilidad-4645)
    • Esteve strengthens its position in the USA with the purchase of TerSera’s infusion therapies (https://www.diariomedico.com/farmacia/industria/esteve-fortalece-eeuu-compra-terapias-infusion-tersera.html)
    • Italfármaco announces a €10 million investment in its Madrid center (https://diariofarma.com/2026/01/12/italfarmaco-anuncia-una-inversion-de-10-millones-de-euros-en-su-centro-madrileno)
    • Rob Surgical will invest €50 million and open its surgical robot plant in El Prat. Bitrack, the first surgical robot designed and manufactured in Catalonia, is moving towards the market (https://www.expansion.com/catalunya/2026/01/16/696aabf0e5fdea60278b458f.html)

7 days in healthcare (December 29th 2025-January 4th 2026)

 

Summary

The most impactful health news of the week included:

  • Biomedicine: What science will surprise us with, six medical advances for 2026.
  • Global health: There is no health without peace. Conflicts are the greatest threat to health.
  • International health policy: China leads research in 90% of crucial technologies, the most dramatic change of this century.
  • National health policy: The 2026 budgets remain up in the air, paralyzing healthcare investments.
  • Companies: Tariff pressure and preferential agreements: Trump’s policy that has managed to segment the pharmaceutical industry in 2026.

Biomedicine

  • What science will surprise us with, six medical advances for 2026: 1. Boost to gene editing; 2. Massive liquid biopsy; 3. Single-cell resolution; 4. Regenerative medicine: bioprinting; 5. Triple immunotherapy for a lethal cancer; and 6. Functional cure for HIV, closer than ever.
  • The 11 trials that will define 2026, according to Nature. Among others: Tuberculosis vaccine; Treating long COVID; Targeted cancer therapy; Metastatic breast cancer; Reducing heart attacks…

Global Health

  • There is no health without peace. What will be the biggest challenge for health in 2026: climate change? AI? Pandemics? Non-communicable diseases? These problems will continue to be a major issue, but across the globe, conflicts will continue to be the primary determinant of people’s health and the functioning of healthcare systems. The impact of armed conflict and violence globally is unusually high.

International Health Policy

  • China leads research in 90% of crucial technologies, the most dramatic shift of this century. The US was ahead in the remaining areas, 74 technologies.
  • The US administration has released its proposed Medicare pricing model. This model will be mandatory for companies that want to sell medications to Medicare and will require price reductions if prices are higher than those in “comparable countries.”
  • Democrats are preparing to capitalize on public discontent regarding the expiring Obamacare subsidies. These subsidies will end next Thursday, and Democrats are working to make this a key issue in the upcoming midterm elections.
  • “Hospital at home” aims to revolutionize the British National Health Service. The idea is that instead of patients having to go to the hospital, healthcare professionals will visit the patient at home.

National Health Policy (Spain)

  • The 2026 budget remains uncertain, paralyzing healthcare investments. The deficit target is fundamental for the National Health System (NHS), as it establishes the necessary financial framework for determining the resources available for key health policies and programs. The planned budget guidelines include an ambitious technological modernization plan, reducing hospital obsolescence, digitizing processes, and launching strategic projects such as the Healthcare Data Lake, along with funding for the future State Public Health Agency.
  • The State Public Health Agency, the Framework Statute, the Tobacco Law, and the Patient Organizations Law are pending healthcare issues for 2026.
  • An overview of vaccination in pharmacies: Spain goes against the grain of most Western countries. Much of the EU and countries like the United States, Canada, and the United Kingdom allow pharmacists to prescribe and administer vaccines.
  • The “ugly duckling” of healthcare: very few dentists in the public system, no specializations, and too many graduates. In 2024, there were 42,860 dentists in Spain, making it the fifth country in the European Union with the highest density of professionals per capita. However, it is the only one of the 27 EU countries where dentists cannot officially specialize.

Companies

  • International
    • Tariff pressure and preferential agreements: Trump’s policy that has segmented the pharmaceutical industry in 2026. Donald Trump’s return to the US presidency in 2025 has only increased uncertainty in the pharmaceutical industry, mainly due to the numerous tariffs announced throughout the year. The policy imposed by the American has not been a simple linear increase in taxes, but a complex system of tariff threats ranging from 15% to 250%. Furthermore, Trump has combined this “model of fear” with negotiated exemptions for companies and countries that commit to reducing the price of medicines in the US market or to relocating their production to American territory.
    • Rare diseases, a growing priority for the pharmaceutical industry. The EU framework for orphan medicines aims to promote the development and marketing of medicines for patients with rare diseases by offering incentives to developers.
  • National
    • Quirón and Ribera Salud managed to attract 250,000 patients from the Madrid public healthcare system thanks to free choice. In contrast, La Paz, Ramón y Cajal, and 12 de Octubre, as well as almost all directly managed hospitals, lost patients in 2024.

Biomedicine

  • What science will surprise us with: six medical advances for 2026: 1. Boost to gene editing; 2. Massive liquid biopsy; 3. Single-cell resolution; 4. Regenerative medicine: bioprinting; 5. Triple immunotherapy for a lethal cancer; and, 6. Functional cure for HIV, closer than ever (https://www.diariomedico.com/medicina/investigacion/sorprendera-ciencia-6-avances-medicina-2026.html)
  • The 11 trials that will define 2026, according to Nature. Among others: Tuberculosis vaccine; Treating long COVID; Targeted cancer therapy; Metastatic breast cancer; Reducing heart attacks… (https://www.elespanol.com/ciencia/salud/20260102/reducir-infartos-vacuna-tuberculosis-ensayos-clinicos-van-marcar-nature/1003744075656_0.html)
  • 2025 marks a turning point in the fight against Alzheimer’s, cancer, and ALS. In the past year, scientific innovation has taken decisive steps, which are already translating into increased survival rates and a better quality of life (https://www.eldebate.com/salud-y-bienestar/20260101/2025-marca-antes-despues-lucha-contra-alzheimer-cancer-ela_370253.html)
  • Artificial intelligence projects that will shape the roadmap for 2026: towards “ultra-precision” medicine (https://gacetamedica.com/investigacion/proyectos-inteligencia-artificial-marcaran-hoja-ruta-2026/)
  • The drug that promises to revolutionize alopecia, after a clinical trial with more than 1,500 patients (https://www.elespanol.com/ciencia/salud/20260103/farmaco-promete-revolucionar-alopecia-enhorabuena-anos-sin-nuevas-terapias/1003744076620_0.html)
  • Goodbye to injections for diabetics: the “sticker” that adheres to the skin to control glucose, thanks to sweat (https://www.elespanol.com/omicrono/tecnologia/20251229/adios-pinchazos-diabeticos-pegatina-adhiere-piel-controlar-glucosa-gracias-sudor/1003744065611_0.html). The device’s features have been published in the journal Science Advances: https://www.science.org/doi/full/10.1126/sciadv.adt4923
  • A study by the University Clinic of Navarra (CUN) says that surgery is more effective for weight loss than drugs in the Ozempic family (https://www.elmundo.es/ciencia-y-salud/salud/2025/12/29/6952473cfdddff985f8b4575.html). Access the original article: https://onlinelibrary.wiley.com/doi/abs/10.1002/oby.70100

Global Health

  • There is no health without peace. What will be the biggest challenge to health in 2026: climate change? AI? pandemics? non-communicable diseases? These problems will continue to hit us hard, but across the globe, conflict will remain the primary determinant of people’s health and the functioning of health systems. The impact of armed conflict and violence globally is unusually high (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02596-6/fulltext).
  • Magical thinking will not prevent future pandemics or improve public health. Science magazine is surprised by a recent article by the director and deputy director of the National Institutes of Health (NIH) in which they state that individual preparedness is the primary weapon against pandemics, downplaying collective efforts and community action (https://www.science.org/doi/10.1126/science.aee2611). Access the cited article by the NIH director: https://www.city-journal.org/article/nih-jay-bhattacharya-covid-pandemic-lab
  • Aid cuts are harming tuberculosis care in Nepal, which is increasing its domestic health spending to compensate for the funding withdrawal (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02469-9/fulltext)
  • How Cameroon is struggling to save its malaria program after cuts in US aid. In northern Cameroon, health workers try to protect children (https://www.nytimes.com/2025/12/28/health/malaria-cameroon-usaid-pmi.html)

International Health Policy

  • USA
    • The Administration makes public the proposed Medicare pricing model. The model will be mandatory for companies that want to sell drugs to Medicare and requires price reductions if prices are higher than those in “comparable countries” (https://www.healthaffairs.org/do/10.1377/forefront.20251223.372648/full/)
    • Democrats prepare to exploit public discontent regarding expiring Obamacare subsidies. These subsidies will end next Thursday, and Democrats are working to make this a key issue in the upcoming midterm elections (https://www.politico.com/news/2026/01/02/democrats-obamacare-subsidies-midterms-00708576)
    • The Trump Administration is giving billions of dollars to rural healthcare. The funds will go primarily to small states that adopt policies favored by the Trump Administration. By this criterion, California and Montana, with a considerable size disparity, will receive the same amount of funding (https://www.politico.com/news/2025/12/29/trump-admin-doles-out-billions-for-rural-health-00707332)
  • China
    • China leads research in 90% of crucial technologies, the most dramatic shift of this century. The USA was ahead in all other areas, with 74 technologies (https://www.nature.com/articles/d41586-025-04048-7)
  • United Kingdom
    • The “hospital at home” aims to revolutionize the NHS. The idea is that instead of patients having to go to the hospital, healthcare professionals will go to the patient’s home (https://www.ft.com/content/13e61375-9036-43b5-9bdc-ff69ddd4ff33)
  • France
    • The fees of private specialist doctors—pediatricians, psychiatrists, neurologists, and dermatologists—will increase starting January 1 (https://www.lemonde.fr/societe/article/2025/12/29/des-le-1-janvier-des-hausses-de-tarif-des-medecins-specialistes-liberaux_6659717_3224.html)

National Health Policy

  • Impact of General Policy on Health
    • The 2026 budget remains uncertain, paralyzing healthcare investments. The deficit target is fundamental for the National Health System (NHS), as it establishes the necessary financial framework for determining the available resources for key health policies and programs. The planned budget guidelines include an ambitious technological modernization plan, reducing hospital obsolescence, digitizing processes, and implementing strategic projects such as the Healthcare Data Lake, along with funding for the future State Public Health Agency. (https://www.consalud.es/politica/los-presupuestos-de-2026-siguen-en-el-aire-paralizando-nuevas-inversiones-sanitarias.html)
  • Central Government Initiatives
    • The Ministry of Health is drafting regulations to limit the working hours of resident physicians (MIRs). The consultation process begins for the future Royal Decree, which will also address specialized healthcare training (https://www.elespanol.com/invertia/observatorios/sanidad/20251229/sanidad-elabora-norma-limitar-jornadas-laborales-mir/1003744072229_0.html)
    • Alleged healthcare VAT fraud of 163 million euros, affecting Salvador Illa’s management as Minister of Health (https://www.elconfidencial.com/espana/2026-01-04/gobierno-silencio-presunto-fraude-iva-sanitario_4276731/)
    • The Treasury will monitor healthcare investments by the autonomous communities, in addition to spending on medicines. The Treasury will expand its monthly monitoring of healthcare spending by the autonomous communities to include, alongside tracking spending on medicines and medical devices, specific monitoring of healthcare investments, with special attention to high-tech hospital equipment. (https://diariofarma.com/2025/12/29/hacienda-monitorizara-las-inversiones-de-las-ccaa-ademas-del-gasto-en-medicamentos)
    • State Public Health Agency, Framework Statute, Tobacco Law, and Patient Organizations Law: pending healthcare issues for 2026 (https://gacetamedica.com/politica/aesap-estatuto-marco-ley-tabaco-asignaturas-pendientes-sanidad-2026/)
  • Initiatives of the autonomous communities
    • The regional gap in healthcare investment will widen even further in 2026. Asturias is the region that will allocate the most budget per person (€2,506) and Murcia has the lowest per capita healthcare spending (€1,511) (https://theobjective.com/economia/2025-12-30/brecha-presupuestaria-per-capita-sanidad-2026/)
  • Framework Statute
    • Doctors join forces in a common front of mobilizations against the Framework Statute. The main medical unions have met to coordinate a common front and demand their own Statute, rejecting the Draft Law on the Framework Statute of the Ministry of Health (https://www.consalud.es/profesionales/los-medicos-unen-fuerzas-en-un-frente-comun-de-movilizaciones-contra-el-estatuto-marco.html)
  • Vaccinations in Spain
    • An overview of vaccination in pharmacies: Spain is at odds with most Western countries. Much of the EU and countries like the United States, Canada, and the United Kingdom allow pharmacists to prescribe and administer vaccines (https://elglobalfarma.com/farmacia/panoramica-vacunacion-farmacias-espana/)
  • Pharmaceutical World
    • The reference pricing system, key to the sustainability of the National Health System. The Spanish pharmaceutical model revolves around the principle of efficiency and seeks to balance access to innovation with control of public spending. The central pillar of this strategy is the Reference Pricing System, an administrative tool that establishes the maximum amount that the National Health System (NHS) is willing to reimburse for each group of medicines (https://www.consalud.es/industria/el-sistema-de-precios-de-referencia-una-herramienta-clave-para-lograr-cada-ano-la-sostenibilidad-del-sns.html)
    • The Profarma Plan enters a new phase to consolidate Spain as a European pharmaceutical powerhouse. The Ministry of Industry has promoted domestic manufacturing and healthcare autonomy through an incentive system that rewards research excellence, sustainability, and the creation of skilled jobs (https://www.consalud.es/industria/el-plan-profarma-entra-en-su-fase-clave-para-consolidar-a-espana-como-potencia-farmaceutica-europea.html)
    • The Year of the Medicines Act, the Key Project for 2026. The most anticipated legislative reform for the industry will face the beginning of 2026 with the goal of completing its final processing (https://elglobalfarma.com/politica/ley-medicamentos-proyecto-clave-2026/)
  • Dental Care
    • The “ugly duckling” of healthcare: very few dentists in the public system, no specializations, and too many graduates. In 2024, there were 42,860 dentists in Spain, making it the fifth country in the European Union with the highest density of professionals per capita. However, it is the only one of the 27 EU countries where dentists cannot officially specialize. (https://www.elconfidencial.com/salud/2026-01-02/odontologia-sanidad-espana_4276623/)

Companies

  • International
    • Tariff pressure and preferential agreements: Trump’s policies have segmented the pharmaceutical industry in 2026. Donald Trump’s return to the US presidency in 2025 has only increased uncertainty in the pharmaceutical industry, mainly due to the numerous tariffs announced throughout the year. The policy imposed by the American president has not been a simple linear increase in taxes, but a complex system of tariff threats ranging from 15% to 250%. Furthermore, Trump has combined this “model of fear” with negotiated exemptions for companies and countries that commit to reducing the price of medicines in the US market or to relocating their production to American territory. (https://www.consalud.es/industria/presion-arancelaria-y-acuerdos-de-favor-la-politica-de-trump-que-ha-conseguido-segmentar-la-industria-farmaceutica-en-2025.html)
    • Rare diseases, a growing priority for the pharmaceutical industry. The EU framework for orphan medicines aims to promote the development and marketing of medicines for patients with rare diseases by offering incentives to developers. (https://elglobalfarma.com/industria/enfermedades-raras-prioridad-industria-farmaceutica/)
  • National
    • Novo Nordisk fined for irregular promotion of its obesity drug in Spain (https://theobjective.com/economia/2026-01-01/novo-nordisk-multada-promocion-irregular-farmaco-obesidad/)
    • Insurance premiums vary by more than €2,200 per year, depending on age and the number of insured persons. Age increases the premium, especially for more comprehensive policies designed for intensive use of the insurance. (https://www.elespanol.com/observatorio-seguros/20251231/prima-seguro-salud-varia-euros-anuales-edad-numero-asegurados/1003744072124_0.html)
    • The clinic partly owned by Guardiola will open in Madrid, Bilbao, and Marbella and has its sights set on Europe. It is Monarka Clinic, specializing in regenerative medicine and neurolongevity (https://www.eleconomista.es/retail-consumo/noticias/13709638/12/25/la-clinica-participada-por-guardiola-abrira-en-madrid-bilbao-marbella-y-mira-hacia-europa.html)
    • Quirón and Ribera Salud managed to attract 250,000 patients from the Madrid public healthcare system thanks to free choice. Conversely, La Paz, Ramón y Cajal and 12 de Octubre, as well as almost all hospitals under direct administrative management, lost patients in 2024 (https://www.eldiario.es/sociedad/quiron-ribera-salud-lograron-captar-250-000-pacientes-sanidad-publica-madrid-gracias-libre-eleccion_1_12881020.html)

 

 

7 days in healthcare (December 15th-21st, 2025)

 

Summary

The most impactful health news of the week included:

  • Biomedicine: Viruses vs. bacteria: Phages become the new hope against antibiotic resistance.
  • Global health: The tobacco epidemic hits people with mental health problems.
  • International health policy: Trump announces price agreements with 9 pharmaceutical companies.
  • National health policy: The call for applications for the location of the State Public Health Agency is published in the Official State Gazette (BOE).
  • Business: Pascal Soriot, CEO of AstraZeneca: “The pharmaceutical industry will be relegated to the past in Europe within fifteen years.”

Biomedicine

  • Viruses vs. bacteria: Phages become the new hope against antibiotic resistance. This therapy, relegated after the discovery of penicillin, has resurfaced in recent years due to the loss of effectiveness of antibiotics. This problem causes more than 24,000 deaths annually in Spain.

Global Health

  • The tobacco epidemic hits people with mental health problems. People with mental illness tend to live shorter lives than the general population. This is believed to be largely due to tobacco abuse.

International Health Policy

  • Trump announces price agreements with 9 pharmaceutical companies. The new agreements, signed by Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead, GSK, Merck, Novartis, and Sanofi, join those already in place with AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk, and Pfizer.
  • 2025: an “annus horribilis” for healthcare in the USA. Of the 218 executive orders signed by Trump, many affect childhood vaccinations against hepatitis B, USAID, immigrants, academics and their institutions, developing countries through the closure of USAID, and Medicaid cuts. A world that would have seemed surreal to us not so long ago.
  • Moderate House Republicans, in line with Johnson’s health care plan, seek to avoid extending Obamacare subsidies.
  • Research funding under threat at the NIH. So far this year, the Trump Administration has fired more than 1,000 NIH scientists and administrators and cut more than 1,000 project grants.

National Health Policy (Spain)

  • The call for applications for the location of the State Public Health Agency has been published in the Official State Gazette (BOE). Applications that provide facilities for the Agency from the outset will be given preference. Autonomous communities will have one month to submit their applications.
  • The decentralization of Medicine in Galicia is unblocked. An agreement has been reached by the rectors of the universities of Santiago, A Coruña, and Vigo.
  • Report on Human Resources in the National Health System (SNS) 2024. Healthcare staffing has grown by 25% in hospitals over 10 years, while primary care staffing has stagnated. The National Health System (SNS) employs 786,747 professionals, a figure that translates to a rate of 16.3 per 1,000 inhabitants.
  • The Ministry of Health reached an agreement with non-medical healthcare unions (SATSE, FSS-CCOO, UGT, CSIF, and CIG-Saúde), but this did not stop the doctors’ strike, promoted by the CESM and the SMA.

Companies

  • International
    • Pascal Soriot, CEO of AstraZeneca: “The pharmaceutical industry will be relegated to obsolescence in Europe within fifteen years.” The main threat is Trump’s policies, which will concentrate all new production in the USA.
  • National
    • Ozempic leads revenue in Spanish pharmacies with €403.9 million. Semaglutide, the active ingredient in Ozempic and Wegovy, consolidated its position in 2024 as the highest-selling molecule in Spanish pharmacies. In total, it received €403.9 million, 36.2% more than the previous year, according to the report “Pharmaceutical Services in the National Health System (NHS).”
    • Quirón reactivates its private hospital in Nuevo Gijón with progress in the municipal agreement for the purchase of land.

Biomedicine

  • The American Heart Association is reviving the theory that moderate alcohol consumption can be healthy. This is published in a recent article, contrary to the opinion of other groups, such as the European Network of Cardiologists and the World Federation of Cardiology (https://www.nytimes.com/2025/12/16/health/alcohol-heart-disease-cancer.html)
  • 78% of breast cancers are diagnosed after menopause: key points (https://www.abc.es/salud/enfermedades/canceres-mama-diagnostican-tras-menopausia-claves-entender-20251218101328-nt.html)
  • More cheese, less dementia? A surprising study links full-fat dairy products with good brain health. This is suggested by a new article published in Neurology and conducted in Sweden (https://www.abc.es/salud/enfermedades/queso-demencia-estudio-sorprende-vincular-lacteos-grasos-20251217170004-nt.html)
  • Viruses versus bacteria: phages become the new hope against antibiotic resistance. This therapy, relegated after the discovery of penicillin, has resurfaced in recent years due to the loss of effectiveness of antibiotics. This problem causes more than 24,000 deaths annually in Spain. (https://www.elespanol.com/ciencia/salud/20251215/virus-bacterias-fagos-convierten-nueva-esperanza-resistencia-antibioticos/1003744050192_0.html)
  • Are some types of sugar healthier than others? Although some sugars (brown sugar, coconut sugar, etc.) are said to be healthier, all types of sugar contain glucose and fructose and are equally harmful. The important thing is not the type of sugar but how it is consumed. In the form of sugary drinks, it is absorbed more quickly and its effects are worse (https://www.economist.com/science-and-technology/2025/12/12/are-some-types-of-sugar-healthier-than-others).

Global Health

International Health Policy

  • USA
    • 2025: an “annus horribilis” for health in the USA. Of the 218 executive orders signed by Trump, many affect childhood hepatitis B vaccinations, USAID, immigrants, academics and their institutions, developing countries through the closure of USAID, and Medicaid cuts. A world that would have seemed surreal to us not so long ago. (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02588-7/fulltext)
    • A MAHA (Make America Healthier Again) fact check in the journal Health Affairs. The article analyzes the negative aspects of the vaccine approach, along with the perhaps positive aspects of the chronic disease approach (https://www.healthaffairs.org/do/10.1377/forefront.20251212.798664/full/)
    • RFK, Jr. wants to incorporate the Danish vaccination schedule, but is forced to back down. The Danish schedule proposes immunization for only 10 of the 17 diseases considered in the USA. Although everything was prepared for the press conference, it had to be interrupted and the measure was dropped (https://www.politico.com/news/2025/12/20/rfk-kennedy-danish-vaccine-schedule-denmark-00701999)
    • Trump announces price agreements with 9 pharmaceutical companies. The new agreements, signed by Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead, GSK, Merck, Novartis and Sanofi, join those already in place and signed with AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk and Pfizer. (https://www.politico.com/news/2025/12/19/trump-unveils-drug-pricing-deals-with-nine-drugmakers-touting-impact-on-affordability-00700957)
    • Moderate House Republicans, in line with Johnson’s health plan, which seeks not to extend Obamacare subsidies (https://www.politico.com/news/2025/12/15/house-gop-moderates-signal-theyll-fall-in-line-with-johnsons-health-plan-00692138)
    • Trump wants to ban transgender treatments for minors, threatening hospitals that perform them (https://www.nytimes.com/2025/12/18/health/trump-gender-affirming-care-funding.html)
    • Research aid under threat at the NIH. So far this year, the Trump Administration has fired more than 1,000 scientists and administrators from the NIH and cut more than 1,000 project grants (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02590-5/fulltext)
    • Trump signs an executive order relaxing marijuana restrictions (https://www.politico.com/news/2025/12/18/trump-signs-executive-order-to-ease-marijuana-restrictions-00698021)
  • United Kingdom
    • Are Big Pharma companies losing their love for the UK? Recently, Merck and Lilly halted major investments in the UK to invest in the USA (https://www.bmj.com/content/390/bmj.r1988)
  • France
    • Flu: a strong impact during the end of the year. A peak is expected around that time (https://www.lemonde.fr/societe/article/2025/12/17/grippe-un-fort-impact-anticipe-sur-les-hopitaux-pendant-les-vacances-de-fin-d-annee-selon-des-projections-de-pasteur-et-sante-publique-france_6658429_3224.html)
  • European Union
    • The OECD points to shortcomings in the prevention of cardiovascular diseases in the EU. The latest report from the OECD and the European Commission estimates 1.7 million cardiovascular deaths in 2022 and warns of the high health, social, and economic costs. EU (https://www.consalud.es/pacientes/la-ocde-alerta-la-prevencion-y-el-cribado-de-las-enfermedades-cardiovasculares-en-la-ue-es-insuficiente.html)
  • WHO

National Health Policy

  • Central Government Initiatives
    • The “I See” Plan is launched, providing free eyeglasses for children up to a maximum of €100 per beneficiary. (https://elpais.com/expres/2025-12-18/arranca-el-plan-veo-como-puedes-pedir-esta-ayuda-para-que-las-gafas-sean-gratis-para-los-ninos.html)
    • The call for proposals for the location of the State Public Health Agency has been published in the Official State Gazette (BOE). Applications that provide facilities for the Agency from the outset will be given preference. The regions will have one month to submit their applications (https://www.boe.es/boe/dias/2025/12/17/pdfs/BOE-A-2025-25898.pdf)
    • The Government will allocate 152 million euros to promote biomedical research in Spain (https://www.diariomedico.com/farmacia/politica/gobierno-destinara-152-millones-euros-fomentar-investigacion-biomedica-espana.html)
    • The cutting-edge Health PERTE program will continue until 2027. Morant emphasizes the role of the public-private company Terafornt as a key player in “promoting the development and manufacturing in Spain of biotechnological products, health technology, and medicines.” “Innovators” (https://diariofarma.com/2025/12/16/el-gobierno-da-continuidad-al-perte-salud-de-vanguardia-con-un-plan-estrategico-hasta-2027)
  • Initiatives of the Autonomous Communities
    • Granada and Zaragoza, the first cities to submit their candidacy to the State Public Health Agency (https://www.elespanol.com/invertia/observatorios/sanidad/20251218/granada-zaragoza-primeras-ciudades-presentar-candidatura-alojar-agencia-estatal-salud-publica/1003744060216_0.html)
    • The decentralization of Medicine in Galicia is unblocked. Agreement reached by the rectors of the universities of Santiago, A Coruña, and Vigo (https://www.diariomedico.com/medicina/profesion/descentralizacion-medicina-galicia-desbloquea.html)
    • Pané advocates combining different types of incentives to improve working conditions for doctors. It has also rejected the idea of ​​doctors having their own statute (https://www.consalud.es/autonomias/cataluna/pane-defiende-mezclar-diferentes-sistemas-de-incentivos-para-mejorar-las-condiciones-de-los-medicos.html)
  • Health Barometer 2025 (3rd wave)
    • Summary: those who believe the system works well are decreasing, while those who believe it works poorly are increasing. And the waiting time to see a family doctor is increasing (Access the report: https://www.sanidad.gob.es/estadEstudios/estadisticas/BarometroSanitario/Barom_Sanit_2025/BS_2025_3oleada/Es3531mar.pdf
  • Human Resources in the NHS, 2024 Report
    • Access the report: https://www.sanidad.gob.es/estadEstudios/estadisticas/sisInfSanSNS/tablasEstadisticas/InfAnual2024/Monografico_RRHH_2024.pdf
    • Healthcare staff has grown by 25% in hospitals over 10 years, while primary care staffing has stagnated. The NHS employs 786,747 professionals, a figure that translates to a rate of 16.3 per 1,000 inhabitants, reflecting the magnitude of a system highly dependent on healthcare personnel to guarantee its daily operation. (https://www.consalud.es/profesionales/plantillas-sanitarias-en-espana-el-personal-hospitalario-crece-un-25-en-10-anos-y-primaria-se-estanca.html)
  • Framework Statute
    • The Ministry of Health reaches an agreement with non-medical healthcare unions (SATSE, FSS-CCOO, UGT, CSIF, and CIG-Saúde), but it does not stop the doctors’ strike, promoted by CESM and SMA (https://www.elespanol.com/invertia/observatorios/sanidad/20251216/sanidad-llega-pacto-sindicatos-sanitarios-no-frena-huelga-medica-no-abordan-peticiones/1003744056534_0.html)
    • European unions support a specific statute for Spanish doctors. According to the Marburger Bund (medical union, Germany) and Anaao Assomed (medical union, Italy), it is necessary to “respect” the “specific nature” of medical work, since a “single” labor framework for healthcare is “not appropriate” (https://www.redaccionmedica.com/secciones/medicina/los-sindicatos-europeos-apoyan-un-estatuto-propio-de-los-medicos-espanoles-1077)
  • Deaths and cause of death
    • Deaths and cause of death in Spain in 2023 (a 6.1% decrease in deaths compared to 2022) (https://www.sanidad.gob.es/gabinetePrensa/notaPrensa/pdf/Defun101225134104376.pdf)
    • The age-adjusted mortality rate decreased by 7.2% in 2023 (https://www.diariomedico.com/medicina/medicina-preventiva/tasa-mortalidad-ajustada-edad-disminuyo-72-2023.html)
  • Suicides
    • The number of suicides decreased; 3,953 people took their own lives in 2024 (https://www.larazon.es/sociedad/3953-personas-quitaron-vida-espana-2024_202512176942d261af09df50108b2cd9.html)

Companies

  • International
    • The plan to rescue Novo Nordisk. It will focus on anti-obesity drugs and make operational changes (https://www.economist.com/business/2025/12/15/the-plan-to-rescue-novo-nordisk)
    • Pascal Soriot, CEO of AstraZeneca: “The pharmaceutical industry will be relegated to the past in Europe within fifteen years.” The main threat is Trump’s policies, which will concentrate all new production in the USA (https://www.lemonde.fr/economie/article/2025/12/17/pascal-soriot-pdg-d-astrazeneca-l-industrie-pharmaceutique-sera-reduite-a-peau-de-chagrin-en-europe-d-ici-a-quinze-ans_6658285_3234.html)
    • Pfizer anticipates a drop in revenue in 2026, due to the decline in income from COVID-19 and the loss of patents (https://www.consalud.es/salud35/internacional/pfizer-preve-una-caida-de-ingresos-en-2026-por-el-descenso-de-las-ventas-de-productos-covid-y-la-perdida-de-patentes.html)
  • National
    • The CNMC suggests Consider less restrictive alternatives before banning single-use e-cigarettes. The agency recommends reconsidering the limitations on advertising, promotion, and sponsorship of tobacco-related products and devices (https://www.elmundo.es/ciencia-y-salud/salud/2025/12/17/6942d063fc6c83e60c8b459f.html)
    • Ozempic leads revenue in Spanish pharmacies with €403.9 million. Semaglutide, the active ingredient in Ozempic and Wegovy, consolidated its position in 2024 as the highest-selling molecule in Spanish pharmacies. It generated a total of €403.9 million, a 36.2% increase compared to the previous year, according to the report “Pharmaceutical Services in the National Health System (SNS).” (https://www.eleconomista.es/salud-bienestar/noticias/13698096/12/25/ozempic-encabeza-los-ingresos-en-las-farmacias-espanolas-con-4039-millones.html)
    • Biosimilars offer a respite to healthcare spending: Biosim anticipates savings of €22 billion by 2030. The mAbxience plant in León produces two million vials for oncology, hematology, and osteoporosis (https://cincodias.elpais.com/extras/ciencia-salud/2025-12-19/los-biosimilares-dan-un-respiro-al-gasto-del-sistema-sanitario-biosim-preve-un-ahorro-de-22000-millones-de-aqui-a-2030.html)
    • Quirón reactivates its private hospital in Nuevo Gijón with progress in the municipal agreement for the purchase of plots (https://www.lne.es/gijon/2025/12/21/quiron-reactiva-hospital-privado-nuevo-125004791.html)

 

 

7 days in healthcare (December 8th-14th, 2025)

 

Summary

The week’s most impactful health news stories were:

  • Biomedicine: The rarest diseases become treatable.
  • Global Health: Universal health coverage, necessary but still a long way off.
  • International Health Policy: Brussels finalizes pharmaceutical reform to facilitate access to innovation.
  • National Health Policy: The measures being prepared by the government aim to curb privatization.
  • Business: Spain inaugurates its first AI factory for healthcare.

Biomedicine

  • The rarest diseases become treatable. CRISPR technology is ready to treat many rare diseases, previously untreatable.
  • Pharmacogenomics: Clinical progress. Pharmacogenomics is the field that analyzes how genetic variations influence the response to therapy. The feasibility of integrating pharmacogenomics into clinical practice has been analyzed in numerous studies.

Global Health

  • Universal health coverage, necessary but still a long way off. Universal health coverage is based on a very simple idea: every person, everywhere, should be able to access the health services they need, without facing financial ruin. However, the “2025 Global Monitoring Report” shows that 4.6 billion people worldwide lack access to essential health services, and 2.1 billion face financial difficulties in accessing them.
  • COP30: How it failed to meet challenges. COP30, held in Brazil in November 2025, is considered a failed initiative, as it was unable to reach agreements on fossil fuels.

International health policy

  • Brussels finalizes pharmaceutical reform to facilitate access to innovation. The EU reached a provisional agreement to comprehensively renew pharmaceutical legislation, with measures aimed at improving access, strengthening security of supply, and stimulating innovation. One of the key elements is regulatory protection of up to eleven years (8+1+1+1) for innovative medicines that meet certain conditions.
  •  The Republican Party is moving toward letting Obamacare subsidies expire, while Trump promises money for people. It seems the latest idea is to let the subsidies expire and make way for “health savings accounts.”
  • The decline of healthcare in Milei’s Argentina. Since coming to power two years ago, Milei has cut spending on healthcare, education, and science. The current second health minister is a representative of the private sector.
  • The Ecuadorian healthcare system is on the verge of collapse. Hospitals are overflowing and lack supplies, and patients’ lives depend on what they can afford to pay.

National Health Policy (Spain)

  • The measures being prepared by the government aim to curb privatization. Minister Mónica García has announced that she is finalizing regulations to limit the entry of for-profit companies into the management of public healthcare centers. The position stems from two errors: 1) that profit-making in healthcare is illegitimate, which is not considered as such in the General Health Law itself; 2) the substantial advantage of non-profit organizations over for-profit ones, as if cost and quality were not the important factors, and as if mismanagement or unjustifiable privileges for employees were not possible in non-profit organizations.
  • The Ministry has published a document evaluating private healthcare in Spain. It is worth noting that, as the document itself states, this is the first time the Ministry of Health has conducted an analysis of private healthcare, which, apart from other considerations, we consider positive. The Ministry cannot continue to ignore the reality of the private healthcare sector, as it has done until now.
  • The People’s Party (PP) has submitted a non-binding resolution demanding the withdrawal of the reform to the Framework Statute. The People’s Party is also calling for the Minister of Health to appear before Parliament to explain “the chaos caused” by her proposed Framework Statute.

Companies

  • International
    • Novo Nordisk’s stock price has fallen 50% this year and is now trading at a loss, a consequence of its weight-loss drug program. The stock market crash has ended several years of spectacular gains following the approval of Ozempic and Wegowy.
  • National
    • Spain inaugurates its first AI factory for healthcare. Spain, along with Germany and Poland, is one of only three countries in the European Union with two artificial intelligence factories approved by the European Commission.

Biomedicine

  • Pharmacogenomics: Clinical Progress. Pharmacogenomics is the field that analyzes how genetic variations influence the response to therapy. The feasibility of integrating pharmacogenomics into clinical practice has been analyzed in multiple studies (https://www.amjmed.com/article/S0002-9343(25)00389-4/fulltext)
  • The Rarest Diseases Become Treatable. CRISPR technology is poised to treat many rare, previously untreatable diseases (https://www.theatlantic.com/science/2025/12/person-crispr-treatment/685151/)
  • The “Molecular Kinship” of Mental Illnesses: 14 Disorders Share Risk Genetic Variants. A study based on DNA data from one million people sheds light on a biological key to understanding these illnesses (https://elpais.com/salud-y-bienestar/2025-12-10/el-parentesco-molecular-de-las-enfermedades-mentales-14-trastornos-comparten-variantes-geneticas-de-riesgo.html)
  • Progress is being made on a vaccine that prevents triple-negative breast cancer. The vaccine produced an immune response in the majority (74%) of participants, and was also safe and well-tolerated (https://www.abc.es/salud/enfermedades/avanza-vacuna-previene-cancer-mama-triple-negativo-20251211003000-nt.html).

Global Health

  • Universal health coverage, necessary but still a long way off. Universal health coverage is based on a very simple idea: every person, everywhere, should be able to access the health services they need, without facing financial ruin. However, the “2025 Global Monitoring Report” shows that there are 4.6 billion people in the world without access to essential health services and 2.1 billion who had financial difficulties accessing them (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02511-5/fulltext). Access the original document: https://cdn.who.int/media/docs/default-source/gho-documents/gmr-2025_conference-edition_online.pdf?sfvrsn=f8cf10f6_9&download=true
  • A new era for sustainable HIV prevention in Africa. The situation has worsened due to the closure of USAID. The article argues that the only way to prevent HIV/AIDS in Africa is to integrate this assistance into other services (https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(25)00497-8/fulltext)
  • COP30: How it failed to meet challenges. COP30, held in Brazil in November 2025, is considered a failed initiative, as it was unable to reach agreements on fossil fuels. (https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(25)00351-5/fulltext)

International Health Policy

  • USA
    • The regrettable step backward in the USA regarding vaccines. Despite the world experiencing a period of significant scientific progress in vaccines, including the addition of mRNA technology, the US administration is simultaneously shifting from support to skepticism, if not outright boycott. Vaccination is no longer considered a health priority and a civic duty (https://www.ft.com/content/6b4d2745-978f-4f3a-8526-b11646716cfa)
    • The law that saved American vaccines, and which the Secretary of Health wants to destroy. The development of vaccination in the USA is based on a set of laws passed over several decades, always with bipartisan support. This is what Robert F. Kennedy, Jr., Trump’s chosen Secretary of Health, wants to destroy (https://www.healthaffairs.org/do/10.1377/forefront.20251208.922418/full/)
    • The Republican Party is moving toward letting Obamacare subsidies expire, while Trump promises money for people. It seems the latest idea is to let the subsidies expire and make way for “health savings accounts” (https://www.politico.com/news/2025/12/09/gop-obamacare-subsidies-expire-00684115)
  • China
    • China is leading the way in AI governance. China is making great strides in regulating AI, something that should be a global trend (https://www.nature.com/articles/d41586-025-03972-y)
  • United Kingdom
    • The NHS in Scotland needs reforms to survive. Scotland’s NHS will be unsustainable in its current form, according to a recent official report (https://www.bmj.com/content/391/bmj.r2578). Access to the original document “NHS in Scotland 2025. Finance and performance”: https://cdn.who.int/media/docs/default-source/gho-documents/gmr-2025_conference-edition_online.pdf?sfvrsn=f8cf10f6_9&download=true
  • France
    • The Social Security budget announces an €8 billion increase in the healthcare budget between 2025 and 2026 (https://www.lemonde.fr/politique/live/2025/12/09/en-direct-budget-de-la-secu-amelie-de-montchalin-annonce-une-enveloppe-pour-la-sante-de-8-milliards-de-plus-entre-2025-et-2026_6656584_823448.html)
  • Argentina
    • The The decline of healthcare in Milei’s Argentina. Since coming to power two years ago, Milei has cut spending on healthcare, education, and science. The current Deputy Minister of Health is a representative of the private sector (https://www.bmj.com/content/391/bmj.r2284)
  • Ecuador
    • The healthcare system is on the verge of collapse. Hospitals are overwhelmed and lack supplies, and patients’ lives depend on what they can afford to pay (https://elpais.com/america/2025-12-08/la-crisis-de-salud-en-ecuador-toca-fondo-con-cadaveres-entregados-en-cajas-de-carton-y-un-sistema-al-borde-del-colapso.html)
  • European Union
    • Brussels finalizes pharmaceutical reform to facilitate access to innovation. The EU reached a provisional agreement to comprehensively renew pharmaceutical legislation, with measures aimed at improving access, strengthening security of supply, and stimulating innovation. One of the key elements is the regulatory protection of up to eleven years (8+1+1+1) for innovative medicines that meet certain conditions. (https://diariofarma.com/2025/12/11/bruselas-cierra-la-reforma-farmaceutica-europea-para-reforzar-acceso-e-innovacion)
    • The EFPIA doubts that the European pharmaceutical reform will allow innovation to continue. “Although the package contains signs that the EU recognizes the importance of legislation as a key driver of European competitiveness, it is not strong enough to influence European competitiveness.” (https://diariofarma.com/2025/12/11/la-efpia-duda-que-el-acuerdo-farmaceutico-pueda-mantener-la-competitividad-de-la-industria)
    • The Farmaindustria considers the reform of the European Union’s pharmaceutical legislation insufficient. It considers that the agreement reached by the EU Council and the European Parliament “lacks ambition and concrete measures” to maintain competitiveness against the US and Asia. (https://www.diariomedico.com/farmacia/industria/farmaindustria-ve-insuficiente-reforma-legislacion-farmaceutica-ue.html)
  • WHO
    • According to the WHO, there is a need for significant growth in the production of medications to combat obesity. According to the WHO, production must be expanded and prices reduced (https://www.bmj.com/content/391/bmj.r2540)
    • The WHO reaffirms that there is no link between vaccines and autism (https://www.lemonde.fr/sante/article/2025/12/11/l-oms-reaffirme-qu-il-n-y-a-pas-de-lien-entre-les-vaccins-et-l-autisme_6656938_1651302.html)

National Health Policy

  • Central Government Initiatives
    • The measures being prepared by the government aim to curb privatization. Minister Mónica García has announced that she is finalizing regulations to limit the entry of for-profit companies into the management of public health centers (https://elpais.com/sociedad/2025-12-08/las-medidas-que-prepara-el-gobierno-para-afrontar-el-escandalo-de-torrejon-una-ley-para-poner-coto-a-la-privatizacion-denuncia-a-la-fiscalia-y-una-inspeccion.html)
    • The government against the “Alzira model” in public healthcare. Antonio Casado says in “El Confidencial”: Banning private management in eight public hospitals to curb the “profit motive” would be like banning public procurement of private goods to avoid “bribes” (https://blogs.elconfidencial.com/espana/al-grano/2025-12-08/gestion-privada-hospitales-publicos-1hms_4262112/)
    • The ministry releases a document evaluating private healthcare in Spain. It should be noted that, as the document itself states, this is the first time the Ministry of Health has conducted an analysis of private healthcare, which, apart from other considerations, we consider positive. The Ministry cannot continue to ignore the reality of the private healthcare sector, as it has done until now. (https://www.sanidad.gob.es/gabinetePrensa/notaPrensa/pdf/20251091225131137451.pdf)
    • The government considers that almost a third of the hospitals in the National Health System (NHS) are privately managed, which it deems anomalous. Spending in these centers has increased by 84%, reaching 4.8 billion euros. “What was once an exceptional measure has become standard practice,” says the Ministry of Health (https://elpais.com/sociedad/2025-12-09/casi-un-tercio-de-los-hospitales-del-sistema-nacional-de-salud-estan-gestionados-por-la-privada.html)
  • Initiatives of the Autonomous Communities
    • Cantabria will create advanced palliative care and early intervention areas (https://www.redaccionmedica.com/autonomias/cantabria/cantabria-creara-areas-de-cuidados-paliativos-avanzados-y-atencion-temprana-4883)
    • Asturias promotes changes in Health and the SESPA (https://www.consalud.es/autonomias/asturias/nueva-estructura-salud-sespa-modelo-asistencial-eficiente-equitativo.html)
  • Scandal surrounding news from Torrejón Hospital
    • The Community of Madrid The Madrid regional government and the Ribera group both denied the scandal at their first meeting. A statement from the regional government simply disseminated the words of the company’s president, Emmanuel de Geuser, denying any kind of instruction to increase profits (https://elpais.com/sociedad/2025-12-09/la-comunidad-de-madrid-y-el-grupo-ribera-coinciden-en-negar-el-escandalo-del-hospital-de-torrejon-tras-su-primera-reunion.html)
  • Framework Statute
    • Four days of doctors’ strike against the Statute last week (https://www.elmundo.es/ciencia-y-salud/salud/2025/12/09/6937c07b21efa089608b4572.html)
    • The Forum of the Medical Profession supports the strike against the Framework Statute. The Forum of the Medical Profession reaffirms its support to the mobilizations and the four days of national strike, considering that the draft of the Framework Statute does not guarantee real improvements in working conditions or in the quality of care (https://www.consalud.es/profesionales/medicina/el-foro-de-la-profesion-medica-respalda-las-cuatro-jornadas-de-huelga-contra-el-borrador-del-estatuto-marco.html)
    • The People’s Party (PP) has registered a non-binding motion demanding the withdrawal of the reform of the Framework Statute. The PP is also requesting the appearance of the Minister of Health to explain “the chaos caused” by her proposed Framework Statute. (https://www.diariomedico.com/medicina/politica/pp-registra-pnl-exigiendo-retirada-reforma-estatuto-marco.html)
  • Deaths and cause of death
    • Deaths and cause of death in Spain in 2023 (a 6.1% decrease in deaths compared to 2022) (https://www.sanidad.gob.es/gabinetePrensa/notaPrensa/pdf/Defun101225134104376.pdf)
    • The age-adjusted mortality rate decreased by 7.2% in 2023 (https://www.diariomedico.com/medicina/medicina-preventiva/tasa-mortalidad-ajustada-edad-disminuyo-72-2023.html)
  • Hospital Renovation
    • The works that will bring the hospitals of the future. The National Health System (NHS) is undergoing the largest hospital reform since the 1990s: dozens of centers under construction, emblematic demolitions, and new projects that will redefine healthcare. In 2025, centers such as the new University Hospital of Salamanca, the Provincial Hospital of Castellón, and the University Hospital of the Canary Islands (HUC) in Tenerife (following its comprehensive renovation of the Emergency Department and ICU) were inaugurated, while almost all the autonomous communities already have projects underway or out to tender that outline a systemic transformation. With the absence of a national inventory and significant regional differences, this silent process will determine the quality of healthcare in the next decade. (https://www.diariomedico.com/medicina/politica/mapa-sanitario-renovacion-obras-traeran-atencion-hospitalaria-futuro.html)

Companies

  • International
    • Pfizer drastically reduces its workforce in Switzerland while launching a global cost-cutting campaign. The pharmaceutical company will reduce its local team from 300 to around 70 employees before the end of the year (https://www.consalud.es/salud35/internacional/pfizer-recorta-mas-de-dos-tercios-de-su-plantilla-en-suiza-en-plena-expansion-de-su-campana-global-de-ahorro.html)
    • Novo Nordisk’s stock has fallen 50% this year and is now trading against the previous weight-loss drug market. The stock market crash has ended several years of spectacular gains following the approval of Ozempic and Wegowy (https://cincodias.elpais.com/companias/2025-12-11/novo-nordisk-cae-un-50-en-el-ano-y-ya-cotiza-como-si-nunca-hubiera-existido-un-frenesi-de-los-farmacos-para-adelgazar.html)

7 days in healthcare (November 31st-December 7th, 2025)

 

Summary

The most impactful health news stories of the week were:

  • Biomedicine: How science can replace the use of laboratory animals.
  • Global health: Infant mortality is expected to rise again in 2025, for the first time in 25 years, due to reduced development aid.
  • International health policy: Cuba is sinking into a major health crisis.
  • National health policy: Following the Torrejón scandal, the Minister of Health announces a law to prevent the private management of public hospitals.
  • Business: Ribera plans to sell assets in Murcia and Extremadura to improve its balance sheet and seek an investor in 2026.

Biomedicine

  • How science can replace the use of laboratory animals. New technologies using miniature human organs can replace procedures currently performed on animals.
  • An experimental DNA-repairing drug ushers in a new era of regenerative therapies. US scientists have developed a drug that repairs DNA and serves as a prototype for a new class of medications that correct tissue damage caused by heart attacks.

Global Health

  • Child mortality is set to rise again in 2025, for the first time in 25 years, due to reduced development aid. The Gates Foundation’s Goalkeepers report warns that the decline in global health funding is responsible for halting more than two decades of progress. The WHO, in its annual report on malaria, notes that progress against the disease has stalled.
  • Ultra-processed foods: time to prioritize health over profit. The rise of ultra-processed foods in human diets is harming public health by driving chronic diseases globally. Addressing this challenge requires a global response. At the heart of this type of food is the large-scale processing of cheap products: corn, wheat, soy, and palm oil. In many countries, these foods make up 50% of the diet.

International Health Policy

  • Cuba is sinking into a major health crisis. Hospitals are overwhelmed, and the death toll is rising daily. Cuba is experiencing a health crisis of “combined arboviral diseases,” including dengue, chikungunya, oropouche, and other respiratory viruses. It has been known for many years that the Cuban health system is backward, lacking even the most basic technology or medicines.
  • US Republicans still don’t know what to do with Obamacare. The necessary update, or lack thereof, of Obamacare subsidies is a headache for Republicans. This issue was behind the recent US government shutdown.
  • US-UK agreement: the NHS will pay much more for medicines. The agreement involves the US not raising tariffs and increasing the price of new treatments by 25% in the UK.

National Health Policy (Spain)

  • In the wake of the Torrejón scandal, the Minister of Health announced a law to prevent the private management of public hospitals. She denounced the fact that in Madrid, La Paz Hospital loses 50,000 patients a year; the 12 de Octubre Hospital, 25,000; and the Ramón y Cajal Hospital, 30,000, all to the benefit of the Quirón and Ribera concessions in Madrid, with the resulting economic benefits. Despite this announcement, it is highly unlikely that, in the current political climate, this law will be passed. The idea that because a problem arises in one hospital, all public hospital services should be provided by public hospitals, as some seem to advocate, is unacceptable and completely contrary to European experience. Public services can be offered by private companies (properly regulated and with a rigorous agreement), and not all public management should be administrative; public companies, foundations, and consortia should also flourish.
  • An audio recording reveals that Torrejón Hospital is turning away patients to increase profits. The Ribera Group, which manages the hospital, is asking its management to make adjustments to achieve a profit of “four or five million.” The leak of this video is a serious reputational problem for the concession system. However, concessions, in themselves, are a good model. Nevertheless, they require an administration capable of rigorously monitoring activity and promoting transparency. Regarding the changes in patient flow denounced by the minister, the Community of Madrid has established, without properly considering the consequences, free choice of healthcare center, including private-public partnership centers in this system, but with different rules than those for directly managed public hospitals. Private-public partnership centers operate as businesses and are able to optimize their ability to attract patients (in addition to having incentives to do so), while public hospitals are constrained by the rules of the administrative framework. This explains the results of this option, which sometimes have a significant economic impact. While supporting the right to choose, this must be done under the same rules. That’s why it’s necessary to reform the governance and management of public institutions.
  • Keys to the swine fever outbreak: too many wild boars roaming free, a highly contagious virus, and the possible link to the sandwich. After three decades, the dreaded virus has returned to Spain. It is not transmissible to humans: pork products, including sausages, can be consumed.

Companies

  • International
    • Will the next blockbuster come from China? These days, Western pharmaceutical companies and investors are privately alarmed that their companies risk falling behind Chinese innovation.
  • National news
    • Ribera plans to sell assets in Murcia and Extremadura to strengthen its balance sheet and seek an investor in 2026. Vivalto Santé, the owner of the hospital concessionaire Ribera Salud, plans to divest assets in Extremadura and Murcia to improve its balance sheet in preparation for seeking a new financial investor in 2026. This plan appears to be a response to the acquisition of low-value assets, a consequence of the rapid growth through acquisitions in recent years.

Biomedicine

  • Lab-grown genomes capable of altering human DNA. Research shows how synthetic chromosomes can be transferred into human cells with the potential to increase viral resistance. This allows for DNA transformation on a scale not possible with today’s more limited gene-editing techniques (https://www.ft.com/content/8b06f15b-3a4e-49e7-8993-e6d6d5fc2309)
  • How science can displace the use of laboratory animals. New technologies using miniature human organs can replace procedures currently performed on animals (https://www.ft.com/content/4d4e0f4b-b564-432e-a2aa-cba0000013f9)
  • COVID-19: The efficacy and lack of risk of mRNA vaccines demonstrated in a large-scale study, as shown by a French study published in JAMA. It incorporates data from 28 million people (https://www.lemondfr/planete/article/2025/12/04/covid-19-l-absence-de-danger-et-l-efficacite-des-vaccins-a-arn-messager-demontrees-par-une-vaste-etude_6656015_3244.html)
  • A key mechanism driving metastasis in cancer has been discovered. The advance provides a deeper understanding of DNA and RNA modifications in metastatic cancer (https://theobjective.com/sociedad/ciencia/2025-12-02/descubren-mecanismo-metastasis-cancer/). Access the original article: https://doi.org/10.1158/0008-5472.CAN-24-3975
  • A vaccine against fentanyl overdose. The first clinical trials for this injection involve the immune system in the treatment of addiction for the first time (https://www.elespanol.com/ciencia/salud/20251205/vacuna-sobredosis-fentanilo-puede-convertir-inmunologia-nuevo-arma-droga/1003744043242_0.html)
  • An experimental drug that repairs DNA ushers in a new phase of regenerative therapies. US scientists have developed a drug that repairs DNA and serves as a prototype for a new class of medications that correct tissue damage caused by a heart attack (https://www.es/salud/enfermedades/farmaco-experimental-repara-dano-causado-infarto-20251203190000-nt.html)
  • Long-term data show that lecanemab slows Alzheimer’s by up to 8.3 years. Eisai presents a study with results from the open-label extension phase of the pivotal trial showing that the greatest benefit is obtained in patients in very early stages (https://www.diariomedico.com/farmacia/industria/datos-plazo-muestran-lecanemab-ralentiza-83-anos-alzheimer.html)

Global Health

  • Ultra-processed foods: time to put health before profit. The increase in ultra-processed foods in human diets is harming public health by driving chronic diseases globally. Addressing this challenge requires a global response. At the heart of these types of foods is the large-scale processing of cheap products: corn, wheat, soy, and palm oil. In many countries, these foods make up 50% of the diet (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02322-0/fulltext)
  • Colombia, a pioneer in taxes on ultra-processed foods. This country introduced a 10% tax on these foods, which will rise to 20% this year. Colombia has a high rate of obesity and hypertension (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02465-1/fulltext)
  • Bill Gates warns that cuts in global aid will increase infant mortality (https://www.ft.com/content/e3f00645-63ee-469e-aa0a-8e82c442519a)
  • Infant mortality is set to rise again in 2025, for the first time in 25 years, due to cuts in development aid. The Gates Foundation’s ‘Goalkeepers’ report warns that the decline in global health funding is responsible for reversing more than two decades of progress. The WHO, in its annual report on malaria, notes that progress against the disease has stalled (https://elpais.com/planeta-futuro/2025-12-04/la-mortalidad-infantil-vuelve-a-subir-en-2025-por-primera-vez-en-25-anos-debido-en-parte-a-los-recortes-de-la-ayuda-al-desarrollo.html)

International Health Policy

  • USA
    • Republicans still don’t know what to do with Obamacare. The need to update Obamacare subsidies is a headache for Republicans. This issue was behind the recent US government shutdown (https://www.economist.com/united-states/2025/12/04/republicans-still-dont-know-what-to-do-with-obamacare)
    • Trump wants a health care deal, leaving the details to Congress (https://www.politico.com/news/2025/12/04/trump-health-care-congress-00675170)
    • Polls suggest voters may blame Republicans if Obamacare subsidies are removed. Half of Americans covered by Obamacare say that increased subsidies could change their vote in the 2026 election (https://www.nytimes.com/2025/12/04/us/politics/poll-republicans-health-insurance-subsidies-affordable-care-act.html)
  • United Kingdom
    • US-UK agreement: The NHS will pay significantly more for medications. The agreement involves the US not raising tariffs and increasing the price of new treatments by 25% (https://www.bmj.com/content/391/bmj.r2538)
  • France
    • France appears poised to withdraw from subsidies for AIDS, tuberculosis, and malaria. For the first time since 2002, these subsidies are being interrupted (https://www.lemonde.fr/planete/article/2025/12/01/sida-la-france-est-elle-en-train-de-se-desengager-du-fonds-mondial_6655544_3244.html)
  • Cuba
    • Cuba is sinking into a major health crisis. Hospitals are overwhelmed and the death toll is rising daily. Cuba is experiencing a health crisis of “combined arboviral diseases” that includes dengue, chikungunya, oropouche, and other respiratory viruses (https://elpais.com/america/2025-12-06/nos-estamos-muriendo-cuba-se-hunde-en-una-gran-crisis-sanitaria-entre-falta-de-medicinas-y-diagnosticos-falsos.html)
  • WHO
    • The WHO supports the drugs Ozempic and Wegovy Mounjaro to combat obesity. These drugs, called GLP-1, mimic the action of this hormone linked to both insulin secretion and the feeling of satiety through brain mechanisms (https://www.elmundo.es/ciencia-y-salud/salud/2025/12/03/692fe66ffdddff9a098b458a.html)
    • European healthcare systems are not prepared to integrate AI. The WHO warns of an uneven implementation of AI in European healthcare. Spain is now among the few countries with its own strategy after approving the eIASNS (https://www.diariomedico.com/medicina/politica/sistemas-sanitarios-europeos-estan-preparados-integrar-ia-segun-oms.html)
  • European Union
    • Pharmaceutical companies are asking the EU to better define what constitutes drugs of interest in the Critical Medicines Act. They have indicated that it should not lead to a proliferation of procedures that reduce the Predictability (https://www.elespanol.com/invertia/observatorios/sanidad/20251203/laboratorios-piden-ue-precise-mejor-farmacos-interes-ley-medicamentos-criticos/1003744041749_0.html)
    • Europe is working on the development of 91 vaccines, 41% of which are dedicated to treatments with no other options (https://diariofarma.com/2025/12/01/europa-trabaja-en-el-desarrollo-91-vacunas-el-41-destinadas-a-tratamientos-sin-opciones)

National Health Policy

  • Impact of General Policy on Health
    • Pedro Sánchez criticizes the PP over the Torrejón hospital scandal (https://elpais.com/sociedad/2025-12-03/la-ministra-de-sanidad-carga-contra-ayuso-por-el-escandalo-del-hospital-de-torrejon-este-es-el-modelo-del-pp.html)
  • Central Government Initiatives
    • Following the Torrejón scandal, the Minister of Health announces a law to prevent the private management of public centers. She reports that in Madrid, La Paz Hospital loses 50,000 patients a year; on October 12th, 25,000; The Ramón y Cajal Hospital, with 30,000 members, always favors the Quirón and Ribera concessions in Madrid, with the consequent economic flow (https://elpais.com/sociedad/2025-12-07/monica-garcia-con-la-nueva-ley-no-se-permitira-el-modelo-de-torrejon.html)
    • The government will prohibit ultra-processed foods on children’s menus in hospitals. Bustinduy announces that the measure will be included in the royal decree on healthy food in hospitals and nursing homes (https://www.abc.es/sociedad/gobierno-prohibira-alimentos-ultraprocesados-menus-infantiles-hospitales-20251126115303-nt.html)
    • Consumer Affairs will require that 80% of the products in vending machines in hospitals and nursing homes be healthy (https://elpais.com/sociedad/2025-12-01/consumo-obligara-a-que-el-80-de-los-productos-de-las-maquinas-expendedoras-de-hospitales-y-residencias-sean-saludables.html)
  • Initiatives of the autonomous communities
    • Andalusia will have 69 new healthcare facilities by 2026. Of these 69 new facilities, 16 are already completed and They will become operational in the first quarter of 2026; 13 are currently under construction and will be ready from April onwards (https://www.redaccionmedica.com/autonomias/andalucia/andalucia-contara-con-69-nuevas-infraestructuras-sanitarias-en-2026-6853)
  • Scandal surrounding news from Torrejón Hospital
    • An audio recording reveals that Torrejón Hospital is rejecting patients to increase its profits. The Ribera group, which manages the hospital, is asking its management to make adjustments to achieve a profit of “four or five million” (https://theobjective.com/espana/politica/2025-12-03/madrid-controles-hospital-torrejon-ardoz-gerente/)
    • The hospital’s management company dismissed four executives who had reported the situation through an internal channel (https://elpais.com/sociedad/2025-12-04/ribera-despidio-a-cuatro-directivos-que-denunciaron-internamente-los-recortes-en-el-hospital-de-torrejon.html)
    • The Community of Madrid denies malpractice at the Torrejón hospital and attributes the scandal to “internal squabbles” (https://elpais.com/sociedad/2025-12-05/la-comunidad-de-madrid-niega-malas-practicas-en-el-hospital-de-torrejon-y-atribuye-el-escandalo-a-rencillas-internas.html)
    • The Ayuso government pays Quirón hospitals double the budgeted amount over four years. The initial funding allocated to the four hospitals for the four-year period 2021-2024 totals €2.543 billion, but the sum of all payments made during those years approaches €5 billion. (https://www.eldiario.es/madrid/gobierno-ayuso-paga-hospitales-quiron-doble-presupuestado-cuatro-anos_1_12818388.html)
  • Framework Statute
    • Doctors call an indefinite strike in January against the Ministry’s Framework Statute. The organizations denounce that Minister Mónica García has no intention of reaching a “fair, useful, and beneficial” agreement (https://elpais.com/sociedad/2025-12-04/los-sindicatos-convocan-una-huelga-indefinida-en-enero-contra-el-estatuto-de-sanidad.html)
    • Latest draft of the Framework Statute (https://gacetamedica.com/wp-content/uploads/2025/12/Propuesta-de-Anteproyecto-de-Ley-del-Estatuto-Marco-del-personal-estatutario-de-los-servicios-de-salud.pdf)
  • Flu epidemic
    • The Ministry of Health and the autonomous communities agree on the flu plan: widespread use of masks and increased vaccination (https://www.elespanol.com/invertia/observatorios/sanidad/20251203/sanidad-ccaa-dan-luz-verde-plan-frente-gripe-mascarillas-obligatorias-medidas/1003744041141_0.html)
  • Swine fever
    • Key points about swine fever: too many wild boars roaming free, a highly contagious virus, and the possible clue of the sandwich. After three decades, the dreaded virus has returned to Spain. It is not transmitted to humans: pork products, including sausages, can be consumed (https://elpais.com/clima-y-medio-ambiente/2025-12-01/claves-de-la-peste-porcina-demasiados-jabalies-sueltos-un-virus-muy-contagioso-y-la-posible-pista-del-bocata.html)
    • The Catalan government commissions an audit amid suspicions that the swine fever virus escaped from a public laboratory. The Catalan government has commissioned an audit by the Institute of Agrifood Research and Technology (IRTA) to analyze whether there has been a possible leak of the African swine fever virus from one of its facilities (https://elpais.com/espana/catalunya/2025-12-06/la-generalitat-encarga-una-auditoria-ante-las-sospechas-de-que-el-virus-de-peste-porcina-escapara-de-un-laboratorio-publico.html)
    • Spain finalizes three live attenuated virus vaccines against African swine fever (https://www.larazon.es/salud/espana-ultima-3-variantes-vacuna-virus-vivos-atenuados-peste-porcina-africana_20251207693161369261f37ec73bde19.html)
    • The swine fever crisis: losses of hundreds Millions, and not just for Catalonia (https://www.elconfidencial.com/empresas/2025-12-06/crisis-peste-porcina-perdidas-cientos-millones_4260876/)

Companies

  • International
    • Will the new Chinese blockbuster arrive? Today, Western pharmaceutical companies and investors are privately raising concerns that their companies risk falling behind Chinese innovation (https://www.ft.com/content/3bfe96d3-593c-498a-9da4-0c1ed359ff74)
  • National News
    • Sanofi, GSK, MSD, Pfizer, and three other laboratories are competing for the Ministry of Health’s mega-contract for 1.7 billion vaccines (https://www.elespanol.com/invertia/observatorios/sanidad/20251202/sanofi-gsk-msd-pfizer-laboratorios-compiten-megacontrato-millones-vacunas-sanidad/1003744037002_0.html)
    • Faes Farma will use its new ophthalmology business to boost its expansion in Latin America and the Middle East (https://www.elespanol.com/invertia/empresas/sanidad/20251204/faes-farma-usara-nuevo-negocio-oftalmologia-impulsar-expansion-latinoamerica-oriente-medio/1003744041715_0.html)
    • Clínica Baviera exploits its “recipe for success” on the Stock Exchange: +650% in five years and a potential of 27% (https://www.elconfidencial.com/mercados/2025-12-03/clinica-baviera-bolsa-informe-cantor-fitzgerald_4258211/)
    • Ribera plans to sell assets in Murcia and Extremadura to clean up its balance sheet and seek an investor in 2026. Vivalto Santé, the owner of the hospital concessionaire Ribera Salud, plans to divest assets in Extremadura and Murcia to improve its balance sheet for the upcoming year. search for a new financial investor in 2026 (https://www.elconfidencial.com/empresas/2025-12-06/ribera-activo-murcia-extremadura-balance-vivalto_4261477/)

7 days in healthcare (November 24th-30th, 2025)

 

Summary

The week’s most impactful health news stories were:

  • Biomedicine: A new AI model improves the diagnosis of rare diseases.
  • Global health: Commitments, voluntary measures, and no mention of fossil fuels—these are the COP30 agreements.
  • International health policy: Trump opens the door to extending Obamacare subsidies.
  • National health policy: Deadly African swine fever returns to Spain after three decades.
  • Business: Vithas Barcelona Hospital, the largest in the network, opens.

Biomedicine

  • A new AI model improves the diagnosis of rare diseases. The innovation promises to offer doctors additional tools for diagnosing certain conditions.
  • An analysis of millions of people confirms that the HPV vaccine prevents cancer. Two large reviews of 132 million people confirm that the HPV vaccine prevents cervical cancer.

Global Health

  • Commitments, voluntary measures, and no mention of fossil fuels: these are the COP30 agreements. The final agreement contains small steps instead of ambitious goals.

International Health Policy

  • Trump opens the door to extending Obamacare subsidies. He says an extension of the subsidies to help families may be necessary.
  • The Trump Administration boasts of achieving $12 billion in savings from negotiating drug prices in Medicare.
  • Argentina faces a historic drop in its vaccination coverage.
  • Measles is resurging as vaccination rates fall, warns the WHO. Measles cases have risen 8% since 2019.

National Health Policy (Spain)

  • The deadly African swine fever returns to Spain after three decades. Catalonia detects two wild boars that died from the disease, which can kill all the pigs on a farm in days. Japan, Mexico, and the United Kingdom have already banned imports of Spanish meat, while China has opted to limit only those from the province of Barcelona.
  • Alert over the H3N2 influenza virus that evades the vaccine. The SiVIRA (ISCIII) confirms that flu cases exceed the epidemic threshold in Spain. Experts explain why the A(H3N2) subclass K virus is more transmissible.

Companies

  • International
    • Bayer announces promising results in trials of a stroke prevention drug.
  • National
    • Vithas Barcelona Hospital, the largest in the network, opens. Spanning over 39,000 square meters, Vithas Barcelona Hospital features 160 single rooms (7 of them suites), 60 specialist consultation rooms, a 24-hour emergency service with separate circuits for adult and pediatric patients, and a full range of services, including a surgical suite with 14 operating rooms.

Biomedicine

  • A different type of dementia is changing what we know about cognitive decline. Many cases labeled as Alzheimer’s are actually cases of LATE (usually less severe than Alzheimer’s) (https://www.nytimes.com/2025/11/28/health/late-dementia-alzheimers.html)
  • Defying death: the origin of aging. This Financial Times series delves into what we really know about aging (https://www.ft.com/content/a33d20fc-c4b5-4790-8f8c-5877f65d4bca)
  • A new AI model improves the diagnosis of rare diseases. The innovation promises to offer doctors additional tools for diagnosing certain problems (https://www.ft.com/content/bc49e334-776b-41d0-a9be-fb0c29c54853)
  • They identify the five phases the brain goes through in life. The research is based on brain scans of 3,802 people between the ages of 0 and 90 (https://www.elespanol.com/ciencia/investigacion/20251125/identifican-fases-pasa-cerebro-vida-cambios-llegan-anos/1003744029169_0.html)
  • An analysis of millions of people confirms that the HPV vaccine prevents cancer. Two large reviews of 132 million people confirm that the HPV vaccine prevents cervical cancer (https://www.abc.es/salud/enfermedades/analisis-sobre-millones-personas-confirma-vacuna-papiloma-20251125101004-nt.html)

Global Health

  • The Global Fund and the future of Global Health. This fund is dedicated to fighting AIDS, tuberculosis, and malaria. The US withdraws from this fund (https://linkinghub.elsevier.com/retrieve/pii/S0140673625024213)
  • Amid massive cuts, the Global Fund reaches $11 billion, from a target of $18 billion (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02419-5/fulltext)
  • Commitments, voluntary measures, and no mention of fossil fuels: these are the COP30 agreements. The final agreement contains small steps, rather than ambitious goals (https://www.theguardian.com/environment/2025/nov/22/roadmaps-adaptations-and-transitions-what-climate-measures-were-agreed-at-cop30)
  • Global leaders must have the courage to end the era of fossil fuels. Despite the meager achievements of COP30, Brazil is prepared to prioritize abandoning fossil fuels (https://www.nature.com/articles/d41586-025-03851-6)
  • Aid cuts: impact on Tanzania. This country is taking steps to reduce and compensate for the lack of foreign aid (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02420-1/fulltext)

International Health Policy

  • USA
    • As the 2026 elections approach, health issues are gaining importance for voters. 4 out of 10 adults who report debt are due to medical or dental bills (https://doi.org/10.1001/jama.2025.24331)
    • Trump opens the door to extending Obamacare subsidies. He says an extension of subsidies to help families may be necessary (https://www.politico.com/news/2025/11/25/trump-obamacare-subsidy-extension-aca-00669491)
    • The Trump Administration boasts of achieving $12 billion in savings from Medicare drug price negotiations (https://www.politico.com/news/2025/11/25/trumps-cms-touts-12b-savings-from-medicare-drug-price-negotiations-00669231)
  • United Kingdom
    • A health minister says the UK should monetize NHS health data. Zubir Ahmed says services from the NHS’s new data center should benefit the public coffers. (https://www.ft.com/content/0531e76b-a800-450f-8a10-ac5ada1b2695)
    • Routine prostate checks rejected by the NHS. Limited follow-up is recommended for people with certain mutations (https://www.ft.com/content/9065a8d8-8bfb-40e7-a64d-a326275a00e8)
  • Argentina
    • Argentina faces a historic drop in vaccination coverage (https://www.lemonde.fr/planete/article/2025/11/28/l-argentine-confrontee-a-une-chute-historique-de-sa-couverture-vaccinale_6655267_3244.html)

National Health Policy

  • Central Government Initiatives
    • The government opens the race to host Certera and details the selection criteria. The government has initiated the process to determine the physical headquarters of the State Network Consortium for the Development of Advanced Therapy Medicinal Products (Certera) and has published the report outlining the criteria that candidates must meet, a key step in accelerating the creation of the future state consortium. (https://diariofarma.com/2025/11/26/el-gobierno-abre-la-carrera-por-la-sede-de-certera-y-detalla-los-requisitos-de-su-eleccion)
  • Regional Government Initiatives
    • Navarre’s biotechnology and pharmaceutical centers are booming. The region boasts the Navarra Health Cluster. This ecosystem represents around 11% of the regional GDP (https://cincodias.elpais.com/extras/navarra/2025-11-29/los-centros-biotecnologicos-y-farmaceuticos-en-plena-expansion.html)
  • African swine fever
    • Four new cases of African swine fever detected in Catalonia. The Catalan animal health center has analyzed samples from the four dead wild boars found in the Collserola mountain range (https://elpais.com/sociedad/2025-11-29/detectados-en-cataluna-cuatro-nuevos-casos-de-peste-porcina-africana-en-el-mismo-radio-de-vigilancia-que-los-dos-primeros.html(https://elpais.com/sociedad/2025-11-28/la-mortifera-peste-porcina-africana-regresa-a-espana-despues-de-tres-decadas.html)
    • The deadly African swine fever returns to Spain after three decades. Catalonia has detected two wild boars that died from the disease, which can kill all the pigs on a farm in days. Japan, Mexico, and the United Kingdom have already banned imports of Spanish meat, while China has opted to limit only those from the province of Barcelona. (https://elpais.com/sociedad/2025-11-28/la-mortifera-peste-porcina-africana-regresa-a-espana-despues-de-tres-decadas.html)
  • Flu Epidemic
    • Alert over the H3N2 influenza virus that evades the vaccine. SiVIRA (ISCIII) confirms that flu cases exceed the epidemic threshold in Spain. Experts explain why the A(H3N2) subclass K virus is more transmissible (https://www.elmundo.es/ciencia-y-salud/salud/2025/11/28/69295e77e4d4d85b6e8b457d.html)
  • Framework Statute
    • Doctors send a new counterproposal to the Framework Statute to the Ministry of Health and will meet next Monday (https://www.elespanol.com/invertia/observatorios/sanidad/20251128/sanidad_-_actualidad_sanitaria-medicos-sanidad_-_profesiones-sanidad_-_medicina-observatorio_de_la_sanidad/1003744033892_0.html)
  • FENIN Report on In Vitro Diagnostics
    • FENIN Press Release (https://fenin.es/wp-content/uploads/2025/11/NP-Fenin-jornada-presentacion-informe-DIV_DEF.pdf). Access the original report: https://fenin.es/wp-content/uploads/2025/11/InformeDIV_2025FeninAAFF.pdf

Companies

  • International
    • Bayer Announces Promising Results in Trials of a Stroke Prevention Drug (https://www.ft.com/content/ff8c225a-90fe-4c0e-a2cf-83877ed9a824)
    • Novo Nordisk’s new drug shows significant weight loss in diabetes trials (https://www.ft.com/content/3b521c6f-f1be-475d-af5e-99ed595dd228)
  • National
    • Vithas Barcelona Hospital, the largest in the network, opens. Spanning over 39,000 square meters, Vithas Barcelona Hospital features 160 single rooms (7 of them suites), 60 specialist consultation rooms, a 24-hour emergency department with separate circuits for adult and pediatric patients, and a full range of services, including a surgical suite with 14 operating rooms. (https://www.elespanol.com/invertia/observatorios/sanidad/20251124/hospital-vithas-barcelona-mayor-compania-inicia-activity-asistencial/1003744027700_0.html)
    • Switzerland gives the green light to a PharmaMar drug for small cell lung cancer (https://www.elespanol.com/invertia/observatorios/sanidad/20251124/suiza-da-luz-verde-lurbinectedina-pharmamar-atezolizumab-cancer-pulmon-celula-pequena/1003744026534_0.html)

7 days in healthcare (November 17th-23rd, 2025)

 

Summary

The week’s most impactful health news stories were:

  • Biomedicine: A new gene-editing strategy could enable the development of treatments for rare diseases.
  • Global Health: Trump’s anti-climate change agenda could cause 1.3 million deaths annually.
  • International Health Policy: In France, medical records can be downloaded directly to mobile phones starting next Tuesday.
  • National Health Policy: “There’s no money for healthcare because the money is in Quirón or in the pockets of millionaires” (statements by the Minister of Health).
  • Companies: Lilly joins the trillion-dollar club thanks to its anti-obesity treatments.

Biomedicine

  • A new gene-editing strategy could enable the development of treatments for rare diseases. Instead of requiring a personalized gene-editing system for each patient, the new approach may allow for a standardized approach for many diseases.
  • An initial look at mRNA vaccines to prevent the flu. These types of vaccines, according to initial studies, may be more effective than traditional vaccines.
  • Chronic kidney disease: breaking the silence. Because it was initially silent, it didn’t receive much attention, but the burden of this disease is growing: 788 million people worldwide have chronic kidney failure.

Global Health

  • Trump’s anti-climate change agenda could cause 1.3 million deaths annually, according to a study. Rising temperatures are already causing a large number of deaths. Trump’s “America First” agenda will increase that number.
  • Bill Gates says that climate change is not as serious as other problems that humanity must address. According to Gates, much progress has been made on the issue of climate change, and although it still represents a serious danger, the most serious threats, especially in poor countries, are poverty and disease. He is receiving strong criticism for this, as it is considered a dangerous distraction.

International Health Policy

  • The digital Vital Card is available on mobile phones throughout France starting Tuesday. It will be available for download on iOS or Android, and this application will allow insured individuals to access their medical records directly from their mobile phones.
  • The NHS is proceeding with its plan to lay off thousands of workers. According to the Secretary of State for Health, this will generate £1 billion in bureaucratic savings over the legislative term, which will be dedicated to improving care.
  • The European Investment Bank is focusing on healthcare. Experts estimate that the closure of USAID will result in 88 deaths per hour. Other estimates put the figure at 14 million deaths by 2030. In response, some Scandinavian countries and philanthropists are increasing aid to these countries, as is the European Investment Bank.

National Health Policy (Spain)

  • There is no money for healthcare because the money is in Quirón or in the pockets of millionaires.” This is the economic analysis of healthcare by the Minister of Health. No comment.
  • Cantabria launches its Healthcare Humanization Plan 2025-2029. Pascual presents a “cross-cutting and comprehensive” strategy that seeks to recover the traditional values ​​of Medicine and restore “necessary silences, reassuring glances, supportive hands, and explanations that bring peace.” An extraordinary step.
  • Cantabria presents its Genomics Strategy 2025-2029, focusing on research and data. Idival reports that the regional cohort has already reached 50,000 volunteers, 20% of the population between 40 and 70 years old. A success for the Cantabria region.
  • The Parliament of Catalonia approves the Integrated Social and Healthcare Agency. A strategic step that connects Catalonia with the most advanced policies in Europe. This step is of utmost importance and will undoubtedly serve as a lesson for many other autonomous communities. Given the prevalence of chronic diseases, the relationship between healthcare and social services is key. •
  • An interesting analysis of the serious situation of waiting lists in Spain (12% of the population at some stage of waiting). “The problem is not money, but the model,” says Juan Abarca in his article, since public healthcare spending has increased by 50% in the last 10 years. He attributes this problem to the refusal to change the administrative management model, so incompatible with efficiency. Despite the seriousness of the problem, this issue is not on the agenda of the Ministry of Health.

Companies

  • International
    • Lilly joins the club of companies with a market capitalization of one trillion dollars, thanks to its anti-obesity treatments
  • National News
    • Santander aims to expand its health insurance business by hiring the CEO of Sanitas. This will likely change the landscape of health insurers in Spain.
    • Palex strengthens its presence in Switzerland with the acquisition of the medtech company Anandic. The group, owned by Apax Partners and Fremman Capital, expands its offering in the hospital sector with the acquisition of the firm, which has a turnover of €37 million and employs around 70 professionals. This is its third acquisition this year.

Biomedicine

  • An initial look at mRNA vaccines for preventing influenza. According to initial studies, these vaccines may be more effective than traditional vaccines (https://www.nejm.org/doi/full/10.1056/NEJMe2514597)
  • Chronic kidney disease: breaking the silence. Because it was initially silent, it didn’t receive much attention, but the burden of this disease is growing: 788 million people worldwide have chronic kidney disease (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02363-3/fulltext). The declaration from the last World Health Assembly urges the prevention and control of this disease: https://apps.who.int/gb/ebwha/pdf_files/EB156/B156_CONF6-en.pdf
  • Lung cancer screening saves lives, but it could save many more. Low-dose computed tomography screening is effective, but it is not performed on more than 80% of potential candidates (https://doi.org/10.1001/jama.2025.23244)
  • Obesity medications will be available globally. The expiration of some patents will help (https://www.economist.com/the-world-ahead/2025/11/12/weight-loss-drugs-will-go-global)
  • A new gene-editing strategy could enable the development of treatments for rare diseases. Instead of requiring a customized gene-editing system for each patient, the new approach may allow for a standardized approach to many diseases (https://www.nytimes.com/2025/11/19/health/gene-editing-rare-diseases.html). Access the original article: https://www.nature.com/articles/s41586-025-09732-2
  • CAR-T immunotherapy is reaching the most common form of heart disease. Modified cells in mice reduced the accumulation of arterial plaque, preventing atherosclerosis (https://www.abc.es/salud/enfermedades/inmunoterapia-cart-llega-forma-comun-enfermedad-cardiaca-20251121122240-nt.html)
  • The cell of origin of Ewing sarcoma has been identified. The discovery, by the Hospital del Mar Research Institute and the Sant Joan de Déu Research Institute, opens the door to new therapies. (https://www.diariomedico.com/medicina/oncologia/identificada-celula-origen-sarcoma-ewing.html)
  • Targeted heat from LED lights: a research avenue for fighting cancer. A team from the universities of Porto and Texas is developing a photothermal system that opens the door to new treatments in outlying areas and even home interventions (https://elpais.com/proyecto-tendencias/2025-11-19/calor-dirigido-con-luces-led-una-via-en-estudio-para-combatir-el-cancer.html). Access the original article: https://doi.org/10.1021/acsnano.5c03135

Global Health

  • Trump’s anti-climate change agenda could cause 1.3 million deaths annually, according to a study. Rising temperatures are already causing a large number of deaths. Trump’s “America First” agenda will increase that number (https://www.theguardian.com/environment/2025/nov/19/trump-emissions-policy-could-cause-climate-deaths). Access the original article: https://www.nature.com/articles/s41598-021-99156-5
  • France is not extending its participation in the fight against AIDS, malaria, and tuberculosis, according to several associations. France, which had pledged €1.596 billion in 2022, has not made any commitments this year (https://www.lemonde.fr/planete/article/2025/11/21/la-france-ne-prolonge-pas-sa-participation-au-fonds-mondial-de-lutte-contre-le-sida-la-tuberculose-et-le-paludisme-selon-plusieurs-associations_6654372_3244.html)
  • Experts warn of the global risk of ultra-processed foods. Three articles published in ‘The Lancet’ highlight the decline in fresh food and the unethical practices of the food industry (https://www.abc.es/salud/enfermedades/aumento-alimentos-ultraprocesados-amenaza-salud-publica-20251119143411-nt.html). Access the original Lancet article: https://www.thelancet.com/series-do/ultra-processed-food
  • Bill Gates says that climate change is not as serious as other problems humanity faces. According to Gates, much progress has been made on climate change, and although it still poses a serious danger, the most serious threats, especially in poor countries, are poverty and disease (https://www.gatesnotes.com/home/home-page-topic/reader/three-tough-truths-about-climate). It has received strong criticism for this, as it is considered a dangerous distraction: https://www.nature.com/articles/d41586-025-03712-2

International Health Policy

  • USA
    • The CDC website is now anti-vaccine, at the direct direction of RFK, Jr. (https://www.theatlantic.com/health/2025/11/cdc-website-autism-vaccine-kennedy/685001/)
    • Certain Republicans in the Senate are working on a plan to lower healthcare costs. There are only a few weeks left before Obamacare subsidies expire and those enrolled will have to pay much more expensive policies (https://www.politico.com/news/2025/11/18/aca-obamacare-subsidies-extension-00655842)
  • United Kingdom
    • The NHS is proceeding with its plan to lay off thousands of workers. According to the health secretary, this will allow for savings of £1 billion in bureaucracy over the legislative term, which will be dedicated to improving care (https://www.bmj.com/content/391/bmj.r2399)
    • The official report concludes that the British government’s response during Covid (Boris Johnson) was insufficient and delayed (https://www.ft.com/content/7ea6f7c8-e59a-466b-964a-8c9acf218415)
  • France
    • The digital version of the Vital Card has been available on mobile phones throughout France since Tuesday. It can be downloaded on iOS or Android, and this application will allow policyholders to access their medical records directly from their mobile phones (https://www.lemonde.fr/societe/article/2025/11/18/la-carte-vitale-dematerialisee-disponible-sur-smartphone-des-mardi-partout-en-france_6653837_3224.html)
  • European Union
    • The European Investment Bank is focusing on health. Experts estimate that the USAID shutdown is causing 88 deaths per hour. Other estimates put the death toll at 14 million by 2030. In response, some Scandinavian countries and philanthropists are increasing aid to these countries, as is the European Investment Bank (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02362-1/fulltext).
    • The ECDC attributes the unusual spread of influenza in Europe to the subclass K A (H3N2) strain (https://diariofarma.com/2025/11/20/el-ecdc-atribuye-el-avance-inusual-de-la-gripe-en-europa-a-la-nueva-cepa-subclade-k).

National Health Policy

  • Central Government Initiatives
    • “There is no money for health because the money is in Quirón or in the pockets of millionaires” (https://www.diariomedico.com/medicina/politica/monica-garcia-hay-dinero-salud-dinero-quiron-o-bolsillos-millonarios.html) and “We are going to create a law that shields the National Health System from privatization ambitions” (https://www.redaccionmedica.com/secciones/parlamentarios/garcia-vamos-a-crear-una-ley-que-blinde-el-sns-de-ansias-privatizadoras–8384)
    • The Ministry of Health allocates 100,000 euros to promote abortion as something positive. According to the document, the aim is to generate “a positive narrative about the exercise of this sexual and reproductive right” (https://theobjective.com/espana/2025-11-20/sanidad-100-000-euros-campana-aborto-positivo/)
    • Countdown to choosing the headquarters of the State Public Health Agency: the regions can now submit their applications. Barcelona, ​​Zaragoza, Granada, León, Oviedo, and Lugo are some of the cities that have applied to host this long-awaited agency (https://www.lne.es/sociedad/2025/11/18/cuenta-elegir-sede-agencia-estatal-salud-publica-comunidades-presentar-candidaturas-123858111.html)
    • All autonomous communities, except the Basque Country and Galicia, have joined the government’s €1.7 billion mega-contract for vaccines (https://www.elespanol.com/invertia/observatorios/sanidad/20251121/todas-ccaa-pais-vasco-galicia-adhieren-megacontrato-vacunas-millones-gobierno/1003744022477_0.html)
  • Initiatives of autonomous communities
    • Cantabria launches its Humanization Plan of Healthcare 2025-2029. Pascual presents a “cross-cutting and comprehensive” strategy that seeks to recover the traditional values ​​of Medicine and return “necessary silences, reassuring glances, supportive hands, and explanations that bring peace” (https://diariofarma.com/2025/11/18/cantabria-inicia-su-plan-de-humanizacion-de-la-asistencia-sanitaria-2025-2029). Access the full text of the Plan: https://saludcantabria.es/documents/20117/200245/Plan%20de%20Humanización%20de%20la%20Asistencia%20Sanitaria%20en%20Cantabria%202025_2029.pdf/37ff204a-9ecb-48c6-035a-c62a2a3eb583
    • Cantabria presents its Genomics Strategy 2025-2029, focusing on research and data. Idival reports that the regional cohort has already reached 50,000 volunteers, 20% of the population between 40 and 70 years old (https://diariofarma.com/2025/11/16/cantabria-presenta-su-estrategia-de-genomica-2025-2029-con-un-enfoque-innovador-en-investigacion-y-datos)
    •  The Parliament of Catalonia approves the Integrated Social and Healthcare Agency. A strategic step connecting Catalonia with the most advanced policies in Europe (https://govern.cat/salapremsa/notes-premsa/765848/el-parlament-de-catalunya-aprova-la-creacio-de-l-agencia-d-atencio-integrada-social-i-sanitaria-agaiss-cat)
    • Valencian Health Service commissions IQVIA to develop the single electronic health record for 69 million euros (https://www.eleconomista.es/salud-bienestar/empresas/noticias/13656394/11/25/la-sanidad-valenciana-encarga-la-historia-clinica-unica-a-la-multinacional-iqvia-por-69-millones-de-euros.html)
  • Healthcare spending
    • Per capita healthcare spending in Spain is 21% of the OECD average (https://www.elespanol.com/invertia/observatorios/sanidad/20251117/gasto-sanitario-per-capita-espana-debajo-media-ocde/1003744013957_0.html)
    • Public spending on healthcare does not exceed the 7% threshold and remains far below the EU average (https://www.elespanol.com/invertia/observatorios/sanidad/20251119/gasto-publico-sanidad-no-salva-barrera-pib-queda-lejos-media-union-europea/1003744018956_0.html)
  • Framework Statute
    • Doctors acknowledge a good relationship with the healthcare system, but admit to “many nuances” in their latest proposal (https://www.elespanol.com/invertia/observatorios/sanidad/20251121/estatuto-marco-medicos-admiten-buena-sintonia-sanidad-reclaman-matices-ultima-oferta/1003744024683_0.html)
  • Sick leave
    • Spanish companies lose €148 billion annually due to sick leave (https://theobjective.com/economia/2025-11-22/bajas-medicas-empresas-perdida-productividad/)
  • Escalation of kidney disease in Spain
    • The unstoppable rise in kidney disease in Spain: 40% more dialysis and transplants in almost 20 years. The increase is not only due to increased life expectancy. This is also due to the fact that the risk factors associated with the disease are not being addressed. (https://www.elespanol.com/ciencia/salud/20251119/imparable-escalada-enfermedad-renal-espana-dialisis-trasplantes-anos/1003744018463_0.html)
  • Analysis of waiting lists in Spain
    • An interesting analysis of the serious situation of waiting lists in Spain (12% of the population in some stage of waiting). “The problem is not money, but the model,” says Juan Abarca in his article, since public healthcare spending has increased by 50% in the last 10 years. He attributes this problem to the refusal to change the administrative management model, which is so incompatible with efficiency (https://www.elespanol.com/opinion/tribunas/20251118/acabar-listas-espera-sanidad-publica/1003744017410_12.html)
  • An interesting article by Víctor Lapuente, professor at the University of Gothenburg: Healthcare for all
    • He calls for increased public resources; less pharmaceutical spending, which is well above the European average; a smaller and unsustainable network of regional hospitals; and more, not less, public-private partnerships. and the streamlining of a highly bureaucratic management system. Without surgery, we accomplish nothing (https://elpais.com/opinion/2025-11-18/sanidad-para-todas.html)

Companies

  • International
    • The American group Abbott invests in cancer screening technology with a $23 billion deal (https://www.ft.com/content/e1a60b35-8b88-474b-a779-64b35889b12e)
    • A new initiative supported by GSK seeks to combat super-resistant bacteria with AI (https://www.ft.com/content/85252c42-0834-487c-9287-3446f838b58e)
    • Lilly joins the trillion-dollar club thanks to its anti-obesity treatments (https://cincodias.elpais.com/companias/2025-11-21/eli-lilly-entra-en-el-club-de-empresas-del-billon-de-dolares-en-bolsa-ante-la-pasion-por-los-tratamientos-anti-obesidad.html)
  • National News
    • Pfizer carries out layoffs in Spain as part of its company restructuring plan (https://www.elespanol.com/invertia/observatorios/sanidad/20251117/pfizer-ejecuta-despidos-espana-parte-plan-reestructurar-compania/1003744014688_0.html)
    • Palex strengthens its presence in Switzerland with the purchase of the medtech company Anandic. The group owned by Apax Partners and Fremman Capital expands its offering in the hospital sector with the acquisition of the firm, which has a turnover of €37 million and employs around 70 professionals. This is its third acquisition this year (https://www.expansion.com/catalunya/2025/11/21/6920bcfa468aeb3a4f8b4575.html)
    • Fedefarma invests €28 million to expand a logistics center in Barcelona (https://www.expansion.com/catalunya/2025/11/21/692048a0468aeb03688b459e.html)
    • Santander aims to grow in health insurance by hiring the CEO of Sanitas (https://www.expansion.com/empresas/seguros/2025/11/21/691f7505e5fdeaf5118b4588.html)

7 days in healthcare (November 10th-16th, 2025)

 

 

Summary

The most impactful health news of the week included:

  • Biomedicine: Scientists are more optimistic about overcoming the global shortage of organs for transplantation.
  • Global health: Fossil fuel projects worldwide threaten the lives of 2 billion people.
  • International health policy: Obamacare could collapse under Trump’s new plan.
  • National health policy: The Prime Minister uses his Wednesday parliamentary address to attack public-private partnerships in healthcare.
  • Business: Pharmaceutical companies’ flattery of Trump could open a European front.

Biomedicine

  • Scientists are more optimistic about overcoming the global shortage of organs for transplantation. A meeting in Geneva confirmed that xenotransplantation is now within reach.
  • A second wave of anti-obesity drugs is on the way. GLP-1 agonists are projected to reach $54 billion in sales by 2024. These drugs, sold under the brand names Wegovy, Ozempic, Mounjaro, and Zepbound, not only allow for weight loss but also have beneficial effects on the heart, liver, and kidneys. The variety of options will increase in 2026, with Novo Nordisk and Lilly preparing pill versions.

Global Health

  • Fossil fuel projects worldwide threaten the lives of 2 billion people. A quarter of the world’s population lives within 5 km of such projects, which potentially threaten their health.
  • Childhood hypertension has doubled in 20 years and is now a global health problem. Researchers attribute this to lifestyle factors: diet and obesity.

International Health Policy

  • Obamacare could collapse under Trump’s new plan, according to political experts. Republicans say that giving the money directly to citizens would give them more control over their coverage. It seems clear that the government shutdown ended in failure for the Democrats, who not only emerged divided but also failed to reach any agreement on healthcare and are handing Trump the complete repeal of Obamacare on a silver platter.
  • The agreement to end the government shutdown puts the healthcare of 24 million people at risk. Republicans are only committing to a vote in December to see if subsidies will continue.
  • China’s CO2 emissions have been flat or declining for the past 18 months. Good news, considering that China is the world’s largest carbon emitter.
  • The WHO director has a message for Trump. He says Trump should reconsider the US withdrawal from the organization.
  • The WHO warns of the tobacco industry’s “attempts to infiltrate” meetings. Days before the anti-tobacco convention meeting, the WHO is commenting on the tobacco industry’s new strategies (e-cigarettes, nicotine patches, and other alternative products). The WHO statement says that “there is no evidence that they benefit public health and growing evidence of their harm.”

National Health Policy (Spain)

  • Sánchez uses his Wednesday parliamentary address to attack public-private partnerships in healthcare. It is hardly tenable to criticize an entire sector from such an important platform, a sector that has undergone significant modernization and growth, and which comprises hundreds of centers, thousands of workers, and serves millions of Spaniards.
  • The government will take Ayuso to court over the list of conscientious objectors to abortion. An administrative lawsuit against the Community of Madrid is announced.
  • The polarization of society in Spain extends to health issues. Pilar Astier, the Spaniard who will preside over the World Federation of Family Doctors, says that “polarization harms health.”
  • The Interterritorial Council of the National Health System (SNS) approves the Artificial Intelligence Strategy for the SNS. Its objective is to coordinate the use of AI in the healthcare system. To this end, a shared governance model is established between the Ministry of Health and the Autonomous Communities.
  • The Ministry and the Autonomous Communities agree to share screening data using three basic indicators. The Ministry accepts that the Autonomous Communities can send information “in any format” regarding the population invited to participate in the screenings, how many respond, and how many test positive. This is good news, which helps to lower the still very high level of polarization.
  • The government agrees to close all poultry farms in Spain due to avian flu. This is the maximum safety measure. Fourteen outbreaks have been identified, which has forced the culling of 2.5 million chickens.
  • Doctors again take to the streets in Madrid and other capital cities to protest Mónica García’s Framework Statute. The CESM and SMA unions are organizing a march, ahead of the four-day strike called for next December. Regardless of the unions’ reasons, the law’s approval is highly unlikely.

Companies

  • International
    • Pharmaceutical companies’ flattery of Trump could open a European front. Executives at major pharmaceutical companies are bowing to Trump, as the US is their most important market. The application of the “most favored nation” clause could force a drop of up to 90% in the price of medicines in the US, which could lead to their withdrawal from Europe to avoid comparisons.
    • Rise and fall of Novo Nordisk, which was once the most valuable company in Europe and has fallen to twelfth place.
  • National
    • Open legal proceedings delay the start of construction on the Quirón hospital in Gijón. The CSI (Leftist Trade Union Current) has filed an appeal with the Supreme Court requesting the annulment of the agreement between the City Council and the company. Quirón made its intentions clear four years ago regarding the construction of a hospital in Gijón.

Biomedicine

  • HealthLocator: A public digital tool for navigating quality of care options. Mayo Clinic researchers have developed a patient tool that integrates publicly available data on outcomes, patient experience, and safety into a single indicator to aid in hospital selection (https://catalyst.nejm.org/doi/full/10.1056/CAT.25.0296).
  • A second wave of obesity drugs is on the way. Known as GLP-1 agonists, these drugs are projected to reach $54 billion in sales in 2024. Marketed under names such as Wegovy, Ozempic, Mounjaro, and Zepbound, they not only promote weight loss but also have beneficial effects on the heart, liver, and kidneys. The range of options will increase in 2026, with Novo Nordisk and Lilly preparing pill-based options (https://www.economist.com/the-world-ahead/2025/11/10/a-second-helping-of-weight-loss-drugs-is-coming)
  • Scientists are more optimistic about overcoming the global shortage of organs for transplantation. A meeting in Geneva found that xenotransplantation is now within reach (https://www.nytimes.com/2025/11/12/health/pig-organs-transplants.html)
  • A new malaria drug promises to defeat resistant strains. A new drug developed by Novartis will help flatten the curve of this disease’s spread in Africa and Asia (https://www.ft.com/content/9070de50-7f26-450f-81c3-6bba45d45bb1)
  • Neural data could be the most valuable information of the decade. New technology will allow us to read our most private thoughts (https://www.ft.com/content/cc0c19e5-fcbc-4324-bf38-34bee0e77842)
  • Research refutes the idea that the microbiome causes autism. The study has been published in the journal Nature (https://elpais.com/salud-y-bienestar/2025-11-13/una-investigacion-rechaza-que-el-microbioma-cause-autismo-no-esta-justificado-dedicar-mas-tiempo-y-recursos-a-esta-hipotesis.html)
  • An inexpensive drug used for gout reduces the risk of heart attack and stroke. A study shows that low-dose colchicine is beneficial for people with cardiovascular disease (https://www.abc.es/salud/enfermedades/farmaco-barato-usado-gota-reduce-riesgo-infarto-20251113092843-nt.html)
  • NextBrain, a brain atlas that reveals subregions for the early detection of neurodegenerative diseases. From Harvard, a team led by the Spaniard Juan Eugenio Iglesias publishes in Nature a high-definition tool that dissects the brain, useful in daily clinical practice (https://www.elmundo.es/ciencia-y-salud/salud/2025/11/16/69176566e4d4d83d388b45a2.html)

Global Health

  • Fossil fuel projects around the world threaten the lives of 2 billion people. A quarter of the world’s population lives within 5 km of these projects, which potentially threaten their health (https://www.theguardian.com/environment/2025/nov/12/fossil-fuel-projects-health-research)
  • Childhood hypertension has doubled in 20 years and is now a global health problem. Researchers attribute this to lifestyle factors: diet and obesity (https://www.elconfidencial.com/salud/2025-11-13/tasas-hipertension-infantil_4245970/)
  • Official statistics underestimate deaths from extreme weather. Research reveals that many more deaths are caused by torrential rains and floods (https://www.nature.com/articles/d41586-025-03669-2)
  • Mpox in Kenya, which is experiencing its first pandemic of this disease (https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(25)02314-1.pdf)
  • Failure is not an option for the new African Medicines Agency. The unequal distribution of vaccines during COVID-19 demonstrates the need to increase production capacity and specific regulation in this area (https://www.nature.com/articles/d41586-025-03668-3)
  • Avoiding the climate “ambition trap.” China has reduced its emissions levels, although some say its ambition is limited (https://www.science.org/doi/10.1126/science.aed3356)
  • Malaria is resurging in Myanmar, raising alarm bells. Cuts in aid funding are undermining eradication efforts (https://www.ft.com/content/6d5e15e4-cff4-415c-996a-643f67bcaef1)
  • Healthcare in Gaza remains in critical condition a month after the ceasefire. There is a shortage of medicines, surgical supplies, and diagnostic equipment (https://elpais.com/planeta-futuro/2025-11-14/la-sanidad-en-gaza-continua-en-cuidados-intensivos-un-mes-despues-del-alto-el-fuego-esto-no-es-vida-esta-realidad-se-parece-a-la-muerte.html)

International Health Policy

  • USA
    • The agreement to end the government shutdown puts the health of 24 million people at risk. Republicans are only committing to a vote in December to see if the subsidies will continue (https://elpais.com/us/2025-11-11/el-acuerdo-para-acabar-con-el-cierre-del-gobierno-pone-en-riesgo-la-sanidad-de-24-millones-de-personas.html)
    • Trump secures the support of 8 Democratic senators to proceed with reopening the government, reaching 60 out of 40 votes, to end the shutdown that has already lasted 40 days (https://www.eldiario.es/internacional/trump-logra-voto-punado-senadores-democratas-acabar-cierre-gobierno-garantizar-ayudas-sanitarias_1_12754636.html)
    • The White House knows it must act to make healthcare economically affordable. Talks among senior administration officials about how to end Obamacare and replace it with another approach are in the preliminary stages (https://www.politico.com/news/2025/11/13/the-white-house-knows-it-needs-to-act-on-health-care-affordability-heres-whats-on-the-table-00649118)
    • Obamacare could collapse under Trump’s new plan, according to political experts. Republicans say that giving the money directly to citizens would give them more control over their coverage (https://www.politico.com/news/2025/11/11/obamacare-could-collapse-under-trumps-new-plan-policy-experts-say-00647246)
    • Food stamps are back, but millions will permanently lose the benefits (https://www.politico.com/news/2025/11/15/food-stamps-snap-trump-one-big-beautiful-bill-impact-00653447)
  • China
    • China’s CO2 emissions have been flat or declining over the past 18 months. Good news, considering that China is the world’s largest carbon emitter (https://www.theguardian.com/world/2025/nov/11/china-co2-emissions-flat-or-falling-for-past-18-months-analysis-finds)
  • United Kingdom
    • Is the NHS on the road to recovery? The waiting list, a closely watched and valued indicator, fell slightly: from 7.41 million in August to 7.39 million in September (https://www.ft.com/content/72bd88d9-fb5d-4f7e-8c34-47ca509994d8)
    • The NHS is in crisis, should I pay for health insurance? According to the author of this article, BUPA’s 15% premium increase led them to cancel their policy (https://www.ft.com/content/69e31e83-1723-4d06-a3a4-f73b6880138f)
  • Canada
    • Canada is no longer a measles-free country after almost 30 years, more than 5,000 cases, and two deaths. This coincides with a decline in vaccination rates (https://www.elespanol.com/ciencia/salud/20251112/canada-deja-pais-libre-sarampion-anos-casos-vacunadosydosmuertes/1003744008116_0.html)
  • World Health Organization
    • The WHO Director-General has a message for Trump. He says Trump should reconsider the US withdrawal from the organization (https://www.politico.com/news/2025/11/09/world-health-organization-tedros-trump-un-global-health-00641160)
    • The WHO warns of the tobacco industry’s “attempts to infiltrate” meetings. Days before the anti-tobacco convention meeting, the WHO speaks out about the tobacco industry’s new strategies (e-cigarettes, nicotine patches, and other alternative products). The WHO statement says that “there is no evidence that they benefit public health and growing evidence of their harm” (https://www.diariomecom/medicina/medicina-preventiva/oms-advierte-intentos-industria-tabaquera-infiltrarse-reuniones.html)
  • European Union
    • Europe cannot be left out of basic health needs. The Hungarian government is sponsoring MEHA (Make Europe Healthy Again), similar to the American initiative, with anti-vaccine messaging. However, Europe faces significant challenges, as highlighted in the “2024 European Health Report” (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02270-6/fulltext?rss=yes). Access the 2024 European Health Report: https://www.who.int/europe/publications/i/item/WHO-EURO-2025-10668-50440-76183

National Health Policy

  • Impact of General Policy on Healthcare
    • Sánchez denigrates private healthcare to attack Ayuso. The president uses his Wednesday parliamentary address to attack public-private partnerships in healthcare (https://www.larazon.es/salud/sanchez-denigra-sanidad-privada-atacar-ayuso_2025111669192475eba8bc0ece00f92b.html)
    • The government will take Ayuso to court over the list of conscientious objectors to abortion. An administrative lawsuit has been announced against the Community of Madrid (https://www.elespanol.com/espana/20251115/monica-garcia-anuncia-llevara-ayuso-tribunales-negarse-crear-registro-medicos-objetores-conciencia/1003744015380_0.html)
    • The polarization of society in Spain is extending to health issues. Pilar Astier, the Spanish woman who will preside over the world’s family doctors, says that “polarization damages health” (https://www.elespanol.com/ciencia/20251113/polarizacion-sociedad-espana-extiende-temas-salud-supone-grave-amenaza/1003744010075_0.html). Article published in Science Advances, demonstrating which factors cause polarization to harm health: https://www.science.org/doi/10.1126/sciadv.ady5064
  • Central Government Initiatives
    • The Interterritorial Council of the National Health System (NHS) approves the Artificial Intelligence Strategy for the NHS. Its objective is to coordinate the use of AI in the healthcare system. To this end, a shared governance model is established between the Ministry of Health and the Autonomous Communities (https://www.sanidad.gob.es/gabinete/notasPrensa.do)
    • The Interterritorial Council of the National Health System approves the Cybersecurity Strategy 2025-2028, a key document to address the growing number of attacks and ensure the confidentiality of medical records (https://www.consalud.es/politica/ministerio-sanidad/el-gobierno-aprueba-la-estrategia-de-ciberseguridad-2025-2028-para-blindar-los-datos-del-sns.html)
    • The Ministry and the Autonomous Communities agree to share screening data with three basic indicators. The Ministry accepts that the autonomous communities can send information “in any format” about the population they invite to screenings, how many respond, and how many test positive (https://www.diariomedico.com/medicina/politica/ministerio-ccaa-acuerdan-compartir-datos-cribados-tres-indicadores-basicos.html)
  • Initiatives of the autonomous communities
    • Catalonia, the first community to launch the national AI plan in healthcare. A €27 million agreement will be signed between Óscar López and Salvador Illa (https://elpais.com/espana/catalunya/2025-11-13/cataluna-primera-comunidad-en-arrancar-el-plan-de-estatal-de-implantacion-de-inteligencia-artificial-en-la-sanidad.html)
    • Catalonia is the region where the waiting list is growing the most, by 8%, while in Castile and León it is falling by 20% (https://www.elespanol.com/invertia/observatorios/sanidad/20251108/cataluna-region-sube-tiempo-espera-operarse-castilla-leon-cae/1003744004747_0.html)
  • Avian flu
    • Government agreement to close all farms in Spain due to avian flu. This is the maximum safety measure. Fourteen outbreaks have been identified, forcing the culling of 2.5 million chickens (https://www.larazon.es/sociedad/gobierno-confina-explotaciones-aves-corral-aire-libre-gripe-aviar_20251113691598e1360d0840bcd57145.html)
    • Avian flu in Spain: how it spreads, detected cases and risk areas (https://www.elcomercio.es/economia/gripe-aviar-espana-contagia-casos-detectados-zonas-20251113140332-ntrc.html)
  • The controversy over breast cancer screening in Andalusia
    • The Andalusian Regional Government goes on the offensive against Amama and officially requests data on the 4,000 people affected by the screenings. The Regional Ministry claims that the figures released by Amama do not correspond to the official figures from the Administration (https://elpais.com/sociedad/2025-11-13/la-junta-de-andalucia-requiere-a-amama-la-informacion-de-las-4000-mujeres-afectadas-por-los-fallos-en-los-cribados.html)
  • Framework Statute
    • Doctors again take to the streets in Madrid and other capital cities to protest Mónica García’s Framework Statute. The CESM and SMA unions are organizing a march, ahead of the four-day strike called for next December (https://www.elconfidencial.com/salud/2025-11-14/manifestacion-medicos-estatuto-marco_4247377/)

Companies

  • International
    • A new pill from Merck may lower cholesterol levels, according to trials, potentially giving millions of people a more affordable way to reduce their risk of heart disease (https://www.nytimes.com/2025/11/08/health/merck-cholesterol-pill-pcsk9.html)
    • The “most favored nation” clause faces legal and operational hurdles for the pharmaceutical industry, according to an analysis by David Cantarero, professor at the University of Cantabria (https://elglobalfarma.com/industria/clausula-nacion-mas-favorecida-obstaculos-legales-operativos-industria-farmaceutica/)
    • Pharmaceutical companies’ flattery of Trump could open a European front. Executives at major pharmaceutical companies are bowing to Trump, given that the US is their most important market. The application of the “most favored nation” clause could force a drop of up to 90% in the price of medicines in the USA, which could lead to their withdrawal from Europe to avoid comparisons (https://cincodias.elpais.com/opinion/2025-11-12/la-adulacion-de-las-farmaceuticas-a-trump-puede-abrir-un-frente-europeo.html)
    • The rise and fall of Novo Nordisk, which was once the most valuable company in Europe and has now fallen to twelfth place (https://cincodias.elpais.com/mercados-financieros/2025-11-13/auge-y-caida-de-novo-nordisk-la-que-fue-empresa-mas-valiosa-de-europa-y-ha-bajado-al-decimotercer-puesto.html)
    • The courts accept the €6.369 billion agreement addressing the role Purdue Pharma’s role in the opioid crisis (https://www.elespanol.com/invertia/observatorios/sanidad/20251114/justicia-acepta-acuerdo-millones-aborda-papel-purdue-pharma-crisis-opiaceos/1003744015122_0.html)
  • National News
    • Almirall’s shares soar by up to 10% on the stock market, as sales improve by 12.8% (https://www.elconfidencial.com/empresas/2025-11-10/almirall-se-dispara-hasta-un-10-en-bolsa_4244833/)
    • Grifols restructures its €1.3 billion debt to facilitate refinancing (https://www.eleconomista.es/salud-bienestar/noticias/13638750/11/25/grifols-armoniza-su-deuda-de-1300-millones-para-facilitar-su-refinanciacion.html)
    • Open legal proceedings delay the start of construction on the Quirón hospital in Gijón. The CSI (Leftist Trade Union Current) has filed an appeal with the Supreme Court requesting the annulment of the agreement between the City Council and the company. It has been four years since Quirón expressed its interest in building a hospital in Gijón (https://www.elcomercio.es/gijon/procesos-judiciales-abiertos-retrasan-inicio-hospital-quiron-20251109000227-nt.html)
    • The pharmaceutical company Medichem (which will create 30 jobs) is finalizing its construction in Asturias (https://www.lne.es/llanera/2025/11/11/farmaceutica-medichem-ultima-obras-nave-123565351.html)